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1.  Einleitung 
 
Die Niere besitzt eine zentrale Rolle bei der Regulation des Elektrolyt-, Wasser- und 
Säure-Basen-Haushaltes. Komplexe, bedarfsorientierte Funktionsprozesse und 
Wechselwirkungen schaffen außerordentliche Lebensbedingungen für die Zellen des 
Organs. Durch das Gegenstromprinzip des Harnkonzentrierungsmechanismus 
entsteht ein cortico-papillärer osmotischer Gradient mit kontinuierlichem Anstieg der 
interstitiellen Teilchenkonzentration von der Nierenrinde zur Nierenpapille. Abhängig 
vom Hydratationsstatus des Organismus variieren die medullären Salz- und 
Harnstoffkonzentrationen erheblich. Die größten Osmolalitätsschwankungen finden 
sich entsprechend diesem Gradienten im Bereich der Papille (76). Bei 
ausgeglichenem Wasserhaushalt des Organismus finden sich dem Blutplasma 
nahezu isoosmolare Bedingungen von 300 mosmol/kg H2O (3). In Antidiurese, dem 
Zustand der systemischen Dehydratation, werden in der Nierenpapille Osmolalitäten 
von bis zu 1200 mosm/kg H2O erreicht. Zur Vermeidung einer „Auswaschung“ der 
zur effektiven Harnkonzentrierung benötigten hohen Salz- und Harnstoff-
konzentrationen besteht im Nierenmark zudem ein relativ geringer Blutfluss, was 
konsekutiv einen niedrigen Sauerstoffpartialdruck bedingt (60). Die Zellen des 
Nierenmarkes besitzen spezifische adaptive und protektive Mechanismen um sich an 
derart lebensfeindliche Bedingungen anzupassen, in dieser Nierenregion zu 
überleben und ihre physiologische Funktion zu wahren.  
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1. 1.  Osmoprotektive Gene 
 
Die vor allem in Antidiurese vorherrschenden extrem hohen Teilchenkonzentrationen 
im Interstitium des Nierenmarkes bewirken die Expression sogenannter 
osmoprotektiver Gene. Zu diesen gehören unter anderem das Enzym Aldose- 
Reduktase (AR), der Betain-γ-Amino-Butyrat-Transporter 1 (BGT1), der Natrium-
abhängige Myo-Inositol-Transporter (SMIT) sowie das Hitzeschockprotein 70 
(HSP70) und die Cyclooxygenase-2 (COX-2). 
Die hohen interstitiellen Osmolalitäten in der Medulla, die zur effektiven 
Harnkonzentrierung benötigt werden, induzieren ohne adaptive Mechanismen einen 
osmotisch bedingten Wasserausstrom aus den Zellen und führen hierdurch zu 
toxischen intrazellulären Ionenkonzentrationen (69). Daher akkumulieren in den 
Zellen des Nierenmarkes metabolisch neutrale, osmotisch wirksame Moleküle, 
sogenannte kompatible organische Osmolyte, welche ein entsprechendes 
osmotisches Gleichgewicht zum Extrazellulärraum herstellen. Von zentraler 
Bedeutung sind Sorbitol, Betain und Myo-Inositol (7, 54). Betain und Myo-Inositol 
akkumulieren in den Nierenmarkszellen durch gesteigerte Aufnahme über 
membranständige Transporter aus dem Extrazellulärraum. Betain wird über den 
Natrium- und Chlorid-abhängigen BGT1 in die Zellen aufgenommen (42). Die 
Anreicherung von Myo-Inositol wird durch den Natrium-abhängigen SMIT reguliert 
(62). Sorbitol akkumuliert durch vermehrte intrazelluläre Synthese durch das Enzym 
Aldose-Reduktase, welches die Reduktion von Glucose in Sorbitol katalysiert. 
Entsprechend dem cortico-medullären osmotischen Gradienten steigt die Expression 
von AR, SMIT und BGT1 vom Cortex bis zur Papille kontinuierlich an. Ihr 
quantitatives Vorkommen ist abhängig vom Diuresezustand des Organismus. In 
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Antidiurese, das heißt bei erhöhter interstitieller Osmolalität, wird die mRNA dieser 
Gene verstärkt exprimiert, während im Zustand der Diurese eine verminderte 
Transkription dieser Gene in der inneren Medulla nachweisbar ist (8).  
Des Weiteren ist die Expression des HSP70 von protektiver Bedeutung. Das 
Chaperon bindet mit seiner Substrat-bindenden Domäne an hydophobe 
Peptidsequenzen von Proteinen (43). Die Expression von HSP70 wird bereits in der 
frühen Phase osmotischen Stresses induziert, es stabilisiert und schützt 
Substratproteine vor Denaturierung und Funktionsverlust (12, 53). Zusätzlich 
antagonisiert HSP70 Caspase-abhängige und Caspase-unabhängige Signalwege, 
die bei osmotischem Stress sowie bei erhöhten extrazellulären Harnstoff-
konzentrationen zur Apoptose führen (39, 63).  
Die Expression der kodierenden Gene für AR, BGT1, SMIT und HSP70 wird durch 
den gemeinsamen Transkriptionsfaktor tonicity-responsive enhancer binding 
protein/nuclear factor in activated T-cells 5 (TonEBP/NFAT5) reguliert (21, 66, 72, 
74). Die entsprechenden Promotorregionen der jeweiligen Gene enthalten das cis-
Element tonicity-responsive enhancer (TonE). Nach Bindung von TonEBP/NFAT5 an 
dieses Sequenzmotiv wird die Transkription der entsprechenden Gene initiiert (35, 
45, 66, 74). Hierfür besitzt das als Homodimer vorliegende TonEBP/NFAT5 die für 
Transkriptionsfaktoren der Rel-Familie typische DNA-Bindungsdomäne. Erhöhte 
extrazelluläre Osmolalitäten bewirken eine vermehrte Expression von 
TonEBP/NFAT5 sowie dessen Phosphorylierung und Translokation vom Zytosol in 
den Zellkern, wo die Bindung an TonE-Elemente erfolgt (9, 17, 56). Im Tiermodell 
führt eine reduzierte TonEBP/NFAT5-Expression zu einer verminderten Expression 
der osmoprotektiven Gene AR, BGT1 und SMIT und geht mit einer 
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schwerwiegenden Schädigung medullärer Zellen sowie einem renalen 
Funktionsverlust einher (40).  
 
 
1. 2.  COX-2  
 
Neben der Expression osmoprotektiver Gene und HSPs spielen das Enzym COX-2 
und deren Produkte wichtige Rollen bei der Anpassung der Nierenmarkszellen an 
hohe interstitielle Osmolalitäten. Die medulläre COX-2-Expression korreliert mit der 
Urinosmolalität und ein Anstieg der interstitiellen Tonizität bewirkt eine Induktion der 
COX-2 auf mRNA- und Proteinebene (79).  
Cyclooxygenasen sind membranständige Proteine. Es existieren zwei Isoformen mit 
ähnlicher Primärstruktur und katalytischer Aktivität, die COX-1 und die COX-2. Beide 
Isoenzyme sind sowohl am endoplasmatischen Retikulum als auch in der 
Kernmembran lokalisiert, wobei die COX-2 vor allem an letzterer Lokalisation 
nachgewiesen werden kann (50). 
Die COX-2 katalysiert den Großteil der im Nierenmark produzierten Prostaglandine 
(79). Die Synthese der Prostaglandine erfolgt in zwei Abschnitten. Nach Freisetzung  
von Arachidonsäure aus Membranphospholipiden durch die zytosolische 
Phospholipase A2 (cPLA2), katalysiert die Cyclooxygenase die Synthese von 
Prostaglandin H2 (PGH2) aus Arachidonat. Das katalytische Zentrum der COX 
besteht aus einer Prostaglandin G–Synthase und einer Prostaglandin H–Synthase. 
Arachidonsäure wird dabei zunächst in einer Cyclooxygenase-Reaktion in 
Prostaglandin G2 (PGG2) und durch anschließende Peroxidase-Reaktion in PGH2 
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umgewandelt (68). In weiteren Schritten werden die unterschiedlichen biologisch 
aktiven Prostaglandine aus PGH2 synthetisiert (51).  
 
 
Abbildung 1.  Biosynthese der Prostaglandine (51). 
 
Während die COX-1 im Organismus ubiquitär konstitutiv exprimiert wird und eine 
Homöostase-Funktion bei der Prostaglandinsynthese wahrnimmt, ist die COX-2 
durch diverse Stimuli induzierbar. Allerdings wird, im Unterschied zu den meisten 
anderen Geweben, im Nierenmark auch die COX-2 konstitutiv exprimiert und kann in 
Antidiurese zusätzlich induziert werden (16, 78, 79, 80).  
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Entsprechend dieser Induzierbarkeit des Enzyms enthält das COX-2-Gen im 
Gegensatz zum COX-1-Gen verschiedene transkriptionsregulierende Sequenzen  
wie κB-Motive und das cAMP-response element (CRE) über die eine Expression der 
COX-2 initiiert werden kann (36). Obwohl die osmoprotektiven Gene für AR, BGT1, 
SMIT und HSP70 durch den Transkriptionsfaktor TonEBP/NFAT5 reguliert werden, 
ist die COX-2-Transkription nicht TonEBP/NFAT5-abhängig. Transkriptionsfördernd 
auf die COX-2 wirken die Transkriptionsfaktoren nuclear factor kappa-light-chain-
enhancer of activated B-cells (NF-κB) und das cAMP-resonse element binding 
protein (CREB), wobei der klassische Induktionsweg im Rahmen entzündlicher 
Prozesse vorwiegend durch NF-κB vermittelt wird (75, 78).  
CREB ist ein über die cyclisches Adenosinmonophosphat (cAMP)-Signalkaskade 
induzierbarer Transkriptionsfaktor und gehört zur Klasse der Leucine Zipper. Seine 
basic leucine zipper (bZIP)-Domäne vermittelt eine Homodimerisierung und die DNA-
Bindung (20). CREB bindet an das cis-Element CRE im COX-2-Promotor. CRE 
enthält 8 Basenpaare mit der Sequenz 5’-TGACGTCA-3’ und ist üblicherweise 
innerhalb von 100 Nukleotiden stromaufwärts der TATA-box lokalisiert (14, 48). 
CREB wird über Phosphorylierung in seiner Kinase-induzierbaren Domäne (KID) 
aktiviert. Dabei erfolgt die Phosphorylierung des Serinrestes an Position 133 der KID 
durch die cAMP-abhängige Proteinkinase A (PKA) (22). Der PKA-Kinasekomplex 
besteht aus einem Tetramer zweier regulatorischer und zweier katalytischer 
Untereinheiten. Nach Aktivierung durch Bindung von cAMP lösen sich beide 
katalytischen C-Untereinheiten und translozieren passiv in den Zellkern (26). Hier 
aktivieren den Transkriptionsfaktor CREB durch Phosphorylierung. Anschließend 
können die Koaktivatoren CREB-binding-protein (CBP) und p300 über ihre KID-
interagierende Domäne KIX den phosphorylierten Serinrest 133 von CREB 
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komplexieren (44, 61). Durch Bindung der Koaktivatoren wird die Transkription des 
CREB-Zielgens COX-2 initialisiert. CBP und p300 interagieren über Rekrutierung der 
RNA-Polymerase II mit der basalen Transkriptionsmaschinerie und initiieren eine 
Interaktion mit dem CRE-gebundenen Transkriptionsfaktor CREB (33, 38). Zudem 
besitzen CBP und p300 Histonacetylase-Aktivität, welche durch Acetylierung von 
Histonen die Chromatinstruktur für eine Bindung der basalen Transkriptions-
maschinerie zugänglich macht (1, 59). 
Die Intensität des extrazellulären cAMP-Stimulus korreliert hierbei mit der Menge der 
in den Zellkern translozierenden C-Untereinheiten der PKA und ist proportional zur 
resultierenden CREB-Aktivität. Reduzierte Signallevel bewirken eine verminderte 
CREB-Phosphorylierung und eine Abnahme der Zielgenexpression (25, 73). 
 
 
Abbildung 2.  cAMP-abhängige CREB-Signalkaskade. 
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1. 3.  Prostaglandin E2  
 
Prostaglandin E2 (PGE2), welches durch die Prostaglandin E-Synthase gebildet wird, 
ist das im Nierenmark quantitativ am stärksten produzierte Prostaglandin (4). PGE2 
wirkt auf auto- und parakrinem Weg nach Bindung an membranständige, G-Protein-
gekoppelte E-Prostanoid-Rezeptoren (EP). Es existieren 4 verschiedene Subtypen 
(EP1-4) mit unterschiedlichen intrazellulären Signalkaskaden. Eine EP1-Stimulation 
bedingt eine intrazelluläre Calcium-Mobilisation durch Aktivierung der Phospholipase 
C, welche die Hydrolyse von Phosphatidylinositol-4,5-bisphosphat (PIP2) zu Inositol-
1,4,5-trisphosphat (IP3) katalysiert. Durch Bindung von IP3 an die IP3-Rezeptoren des 
Endoplasmatischen Retikulums werden Calciumionen aus diesem intrazellulären 
Speicher freigesetzt. Diskutiert wird auch ein weiterer Phospholipase C-
unabhängiger Signalweg, wonach ein extrazellulärer Calciumeinstrom die 
intrazelluläre Calciumkonzentration erhöht. Der EP3-Rezeptor hemmt über ein 
inhibitorisches G-Protein die intrazelluläre Bildung von cAMP. EP2 und EP4 sind Gs-
Protein-gekoppelte Rezeptoren. Ihre Aktivierung durch PGE2 führt über ein 
stimulierendes G-Protein und die Adenylatcyclase zu einer erhöhten intrazellulären 
cAMP-Konzentration (13, 28, 32, 51, 57, 71). Die Bindung von PGE2 an den EP2-
Rezeptor bewirkt über dessen Konformationsänderung die Aktivierung des 
gekoppelten G-Protein-Trimers. Nach Austausch von GDP zu GTP dissoziiert die α-
Untereinheit vom βγ-Komplex und induziert die membrangebundene 
Adenylatcyclase, welche die Reaktion von ATP zu cAMP katalysiert (81). cAMP 
bindet mit hoher Affinität an die regulatorischen Untereinheiten der Proteinkinase A 
(PKA), woraufhin, wie zuvor beschrieben, sich beide katalytischen C-Untereinheiten 
vom Kinasekomplex lösen und nach Translokation in den Zellkern verschiedene 
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Transkriptionsfaktoren durch Phosphorylierung aktivieren.  
 
 
Abbildung 3. Signaltransduktion durch die Prostaglandin E2-Rezeptoren EP1 (A), EP2 (B),              
EP3 (C) und EP4 (D) 
 
Die vier Prostaglandinrezeptor-Subtypen unterscheiden sich nicht nur hinsichtlich 
ihrer Signaltransduktionswege, sondern auch bezüglich ihrer Rolle in der Regulation 
der Nierenfunktion und dementsprechend in ihrer Lokalisation im renalen Zellverband 
(5, 6). Die definitive Verteilung des EP2-Rezeptors ist noch nicht mit Sicherheit 
geklärt. Dieser konnte aber im Nierengewebe verschiedener Spezies in der äußeren 
und inneren Medulla nachgewiesen werden (24, 30, 49). Auch Madin-Darby canine 
kidney (MDCK) Zellen als Modell medullärer Sammelrohrzellen besitzen die 
Rezeptoren EP2 und EP4 (41, 58). Da EP2-defiziente Mäuse einen salz-sensitiven 
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arteriellen Hypertonus entwickeln, wird dem EP2-Rezeptor eine Bedeutung in der 
Regulation des Salzhaushaltes und der Blutdruckregulierung zugesprochen (34). 
 
PGE2 ist für eine normale Nierenfunktion essentiell. Es reguliert die Salz- und 
Wasserreabsorption im medullären dicken aufsteigenden Teil der Henle Schleife 
(mTAL) und im Sammelrohr durch die Inhibition entsprechender Kanäle (29, 31). 
Ferner vermittelt PGE2 die Dilatation der absteigendenen Vasa recta und wirkt somit 
Vasokonstriktoren wie Angiotensin II, Vasopressin und Katecholaminen lokal 
entgegen um die Zellen des Nierenmarkes vor hypoxischer Schädigung zu bewahren 
(52, 54, 60). Durch Steigerung der Expression osmoprotektiver Gene fördert PGE2 
die Anpassung medullärer Zellen an die in dieser Nierenregion vorherrschenden 
hohen Osmolalitäten (46, 54, 55). Des Weiteren konnten PGE2-vermittelte anti-
apoptotische Effekte für verschiedene Zelltypen gezeigt werden (2, 11, 27, 37, 70). 
Der Apoptose-inhibierende Mechanismus wurde als EP2- und EP4-Rezeptor-
abhängiger Signalweg in humanen pulmonalen Fibroblasten, in γ-Strahlung 
ausgesetzten Kryptenzellen des proximalen Jejunums von Mäusen und in UVB-
bestrahlten murinen Hautzellen beschrieben. Letzteres wird über eine EP2-PKA-
abhängige Phosphorylierung und Inaktivierung des proapoptotischen Proteins Bad 
durch PGE2 vermittelt (11, 27, 70). 
 
 
1. 4.  Das Protein Bad und Apoptoseregulation 
 
Bcl-2-associated death promotor (Bad) gehört zur B-cell lymphoma-2 (Bcl-2)-Protein-
Familie und besitzt eine proapoptotische Funktion. Zur Bcl-2-Gruppe gehören 
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homologe Proteine mit antiapoptotischem (Bcl-2, Bcl-xL, Mcl-1, A1) und pro-
apotischem (Bad, Bax, Bak, Bcl-xs) Effekt. Diese sind durch ein bis vier Bereiche 
homologer Aminosäuresequenzen, den sogenannten Bcl-2 homology (BH)-
Domänen, gekennzeichnet (65). Durch Heterodimerbildung unter den einzelnen 
Mitgliedern modulieren diese gegenseitig ihre Funktion und regulieren den 
mitochondrialen Apoptoseweg. Der BH3-Domäne wird eine wichtige Rolle bei der 
Apoptoseeinleitung zugeschrieben. Diese kann bei allen proapoptotischen 
Mitgliedern nachgewiesen werden (10, 15, 23). 
Das BH3-only-Protein Bad besitzt lediglich eine Sequenzhomologie in der BH3-
Domäne. Im unphosphorylierten Zustand ist Bad in der äußeren Mitochondrien-
membran lokalisiert. Die Regulation seiner Funktion erfolgt über Phosphorylierung an 
verschiedenen Serinresten, die durch extrazelluläre Faktoren wie Insulin-like Growth 
Factor-1 (IGF-1), Nerve Growth Factor (NGF), Platelet Derived Growth Factor 
(PDGF) und Interleukin-3 (IL-3) induziert werden kann (18). Unphosphoryliertes Bad 
bildet über die BH3-Domäne Heterodimere mit Bcl-xL und hemmt damit dessen 
antiapototische Funktion (77). Dies bewirkt eine Freisetzung von Cytochrom C aus 
den Mitochondrien und Aktivierung der Caspase-Kaskade (64). Die durch die 
Proteinkinase A vermittelte Phosphorylierung des Serinrest an Position 155 (Ser155) 
verhindert die Bindung der BH3-Domäne von Bad an Bcl-xL und blockiert damit die 
inhibitorische Funktion von Bad auf das antiapoptotische Bcl-xL. Die 
Phosphorylierung an Ser155 scheint somit durch Unterbrechung der intrinsischen 
Apoptosekaskade eine wichtige Rolle für das Zellüberleben zu spielen (19, 82).  
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Abbildung 4.  Das Protein Bad und Apoptoseregulation (19, 82). 
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1. 5.  Zusammenfassung der vorliegenden Arbeiten 
 
Die Zellen des Nierenmarkes sind vor allem in Antidiurese extrem lebensfeindlichen 
Umgebungsbedingungen ausgesetzt. In dieser Nierenregion herrschen nicht nur 
hohe interstitielle Osmolalitäten vor, sondern es erfolgen auch rasche und extreme 
Änderungen der Tonizität beim Übergang von Diurese in Antidiurese und umgekehrt. 
Durch diverse Strategien sichern medulläre Zellen nicht nur ihr Überleben, sondern 
wahren zudem ihre physiologische Funktion. Bei diesem Prozess scheinen eine 
rasche Induktion der COX-2 und die Bildung von PGE2 von entscheidender 
Bedeutung zu sein. Demzufolge kann, insbesondere im dehydrierten Zustand eines 
Organismus, eine pharmakologische Hemmung der COX-2 durch unspezifische 
nicht-steroidale Antiphlogistika oder selektive COX-2-Inhibitoren eine renale 
Gewebeschädigung oder sogar ein akutes Nierenversagen verursachen. 
 
Gegenstand der beiden vorliegenden Arbeiten war die Untersuchung der Rolle von 
COX-2 und PGE2 bei der Osmoadaptation der Zellen des Nierenmarkes sowie deren 
Einfluss auf das Überleben dieser Zellen bei osmotischem Stress. Ferner sollten die 
zugrunde liegenden Signaltransduktionswege charakterisiert werden.    
 
In der ersten Arbeit konnte gezeigt werden, dass PGE2 in kultivierten MDCK-Zellen - 
hier als Modellsystem medullärer Sammelrohrzellen gewählt - das Zellüberleben bei 
einem Anstieg der Umgebungsosmolalitäten maßgeblich begünstigt. Damit 
einhergehend war eine verminderte Aktivität des Apoptosemarkers Caspase-3 
nachweisbar. Unter hypertonen Bedingungen erfolgte eine Induktion der die 
Osmolyt-Akkumulation regulierenden Gene AR, SMIT und BGT1 zeitlich deutlich 
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nach der Induktion von HSP70 und COX-2. Dies deutete darauf hin, dass die 
intrazelluläre Akkumulation signifikanter Mengen an Osmolyten in dieser frühen 
Phase des osmotischen Stresses nicht maßgebend für Zellüberleben ist. Mutmaßlich 
spielen HSP70 und COX-2 zu diesem Zeitpunkt eine entscheidendere Rolle. In 
Gegenwart von exogen zugeführtem PGE2 waren die bereits durch osmotischen 
Stress gesteigerten mRNA-Level der osmoprotektiven Gene AR, SMIT, HSP70 und 
COX-2 nochmals signifikant gesteigert. Es ließ sich eine deutliche Stimulation durch 
PGE2 sowohl auf die AR-Promoter-Aktivität als auch auf die Expression von Aldose-
Reduktase nachweisen. Es zeigte sich allerdings kein Einfluss von PGE2 auf das 
quantitative Vorkommen des Transkriptionsfaktors TonEBP/NFAT5, welcher die 
Expression von AR, SMIT und HSP70 reguliert oder auf eine Ton-E-gesteuerte 
Promotoraktivität. Es war daher anzunehmen, dass der beobachtete PGE2-Effekt 
nicht durch eine gesteigerte transkriptionelle Aktivität von TonEBP/NFAT5 vermittelt 
wird.  
Interessanterweise konnte bei osmotischem Stress ebenfalls eine zusätzliche 
stimulierende Wirkung von PGE2 auf die COX-2-Expression selbst demonstriert 
werden. Diese Beobachtung deutete auf das Vorhandensein eines positiven 
Feedback-Mechanismus hin. Nach Aktivierung des Harnkonzentrierungs-
mechanismus in vivo beobachtet man die Produktion großer Mengen PGE2 in der 
renalen Medulla. Dies könnte durch den im Rahmen der vorliegenden Arbeit 
identifizierten positiven Rückkopplungsmechanismus von PGE2 auf die COX-2-
Expression begünstigt werden. 
 
Die zweite Arbeit untersuchte weiterführend diesen PGE2-vermittelten positiven 
Rückkopplungsmechanismus auf die COX-2-Expression und charakterisierte den 
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zugrunde liegenden Signaltransduktionsweg sowie dessen funktionelle Relevanz auf 
das Zellüberleben bei osmotischem Stress. Der stimulierende PGE2-Feedback-Effekt 
auf die COX-2-Expression, der unter isotonen Bedingungen nicht zu beobachten 
war, ließ sich unter hyperosmolaren Bedingungen auf mRNA- und Proteinebene 
sowie durch eine gesteigerte COX-2-Enzymaktivität nachweisen. Die Gs-Protein-
Kopplung der Prostaglandinrezeptoren und die Tatsache, dass der COX-2-Promotor 
ein funktionelles CRE enthält, ließen vermuten, dass der stimulierende Effekt von 
PGE2 durch einen cAMP-PKA-CREB-abhängigen Signalweg vermittelt wird. Durch 
verschiedene Versuche mit pharmakologischen Agonisten und Inhibitoren konnte ein 
PGE2-vermittelter Signalweg demonstriert werden, der über den Gs-Protein-
gekoppelten Prostaglandinrezeptor EP2 zu einem Anstieg der intrazellulärem cAMP-
Konzentration und Aktivierung der Proteinkinase A führt. Passend zu dieser 
Beobachtung zeigte sich der Effekt von PGE2 ebenfalls in den nachgeschalteten 
Signalwegen in einer (i) Aktivierung von CREB mit (ii) nachfolgender Transkription 
von COX-2-mRNA sowie einer (iii) gesteigerten CRE-abhängigen Reportergen-
Aktivität und (iv) Stimulation der COX-2-Promotor-Aktivität über ein CRE. Auch war 
nach gezielter Mutagenese der mutmaßlich verantwortlichen CRE-Sequenz in einem 
COX-2-Promotor-Reporterkonstrukt der stimulierende Effekt von PGE2 auf dessen 
Aktivität nicht mehr nachzuweisen.   
Ferner ließ sich ein potenziell überlebensfördernder PGE2-abhängiger Mechanismus 
demonstrieren. In Gegenwart von extern zugeführtem PGE2 zeigten sich ein  
verbessertes Zellüberleben sowie eine verminderte Aktivität des biochemischen 
Apoptose-Indikators Caspase-3. Es konnte ein EP2-cAMP-abhängiger Signalweg 
identifiziert werden, der über eine PKA vermittelte Phosphorylierung des 
proapoptotischen Proteins Bad am Serinrest 155 zu dessen Inaktivierung führt. 
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Durch pharmokologische Unterbrechung dieses Signalweges kam es zur Aufhebung 
des positiven PGE2-Effekts auf das Zellüberleben und zur Aktivierung der Caspase-
Kaskade mit erhöhter Caspase-3-Aktivität bei osmotischem Stress.  
 
Zusammenfassend deuteten die Ergebnisse auf einen EP2-cAMP-PKA-CREB-
abhängigen Signalweg hin, welcher durch PGE2 eine gesteigerte COX-2-Expression 
im Sinne eines positiven Rückkopplungseffektes bei osmotischem Stress vermittelt. 
PGE2 förderte zusätzlich die Expression anderer osmoprotektiver Gene. Zudem 
zeigte sich ein antiapoptotischer Effekt durch einen PGE2-EP2-cAMP-PKA-
abhängigen Mechanismus, der zur Phosphorylierung und damit Inaktivierung des 
pro-apoptotischen Proteins Bad führt. Der hier charakterisierte PGE2-Signalweg hat 
funktionelle Bedeutung für die Anpassung der Nierenmarkszellen an ihre 
lebensfeindlichen Umweltbedingungen, ihr  Zellüberleben und die Wahrung ihrer 
physiologischen Funktion bei osmotischem Stress. Eine pathophysiologische 
Bedeutung bei der Entstehung der durch nicht-steroidale anti-inflammatorische 
Medikamente (NSAID) induzierten Nierenschädigung ist zudem zwanglos vorstellbar. 
 
 
Beitrag des Doktoranden zu der in Ko-Autorenschaft publizierten Arbeit: 
Das Konzept der Publikation wurde von PD Dr. Wolfgang Neuhofer ausgearbeitet. 
Die Durchführung und Auswertung der Experimente erfolgte in Zusammenarbeit mit 
Daniela Steinert.  
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Abbildung 5 .  Positiver Rückkopplungseffekt der COX-2 durch PGE2. 
 
 
  
18 
 
 
Abbildung 6.  Antiapoptotischer Effekt durch PGE2-abhängigen Mechanismus.  
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1. 6.  Summary of the present publications 
 
The interstitial environment of the renal medulla is characterized by extremely high 
osmolalities in antidiuesis. And the resident cells are exposed to a rapid increase in 
interstitial tonicity following stimulation of the urinary concentration mechanism. The 
renal medullary cells employ several osmoadaptive strategies to promote cell survival 
and maintain their proper function, thereby preserving renal integrity. Rapid induction 
of COX-2 and subsequent formation of PGE2 plays a critical role in this process. 
Pharmacological enzyme inhibition by non-steroidal anti-inflammatory drugs that 
target COX-2 selectively or non-selectively is known to be associated with structural 
and functional renal damage. 
 
The present studies analyzed the role of COX-2 and PGE2 in osmoadaptation of 
renal medullary cells and addressed their effects on cell survival in the hostile 
environmental of the renal medulla. A further focus was to delineate the underlying 
signaling pathways. 
 
The first section dealt with the role of COX-2 and PGE2 in osmoadaptation. Madin-
Darby canine kidney (MDCK) cells were used as a cell culture model for renal 
collecting duct cells and were exposed to osmotic stress. The presence of 
exogenous PGE2 promoted cell survival significantly under these conditions and 
substantially attenuated caspase-3-activity, a biochemical index of apoptosis. In 
addition tonicity-induced up-regulation of mRNA abundance of the osmosensitive 
genes AR, SMIT, HSP70 and COX-2 were further potentiated in presence of PGE2. 
The induction of HSP70 and COX-2 preceded that of genes that are involved in the 
20 
 
intracellular accumulation of organic osmolytes (AR, BGT1, and SMIT). This is 
consistent with the assumption that in the early phase of osmotic stress cell survival 
and function does not require the accumulation of significant amounts of organic 
osmolytes. However it appears to depend on the induction of HSP70 and COX-2. 
PGE2 further increased the activity of an AR-promoter-driven reporter construct and 
stimulated the expression of AR under hypertonic conditions. Surprisingly, PGE2 had 
no detectable effect on either the abundance of the transcriptional factor 
TonEBP/NFAT5 that stimulates the expression of AR, SMIT and HSP70, or on TonE-
driven promoter activity. These findings indicated that the stimulatory effect of PGE2 
is not mediated by increased TonEBP/NFAT5 activity. 
In addition PGE2 also increased the expression of COX-2 during osmotic stress, 
suggesting the existence of a positive feedback mechanism. In vivo the induction of 
the urinary concentration mechanism and subsequent increase in interstitial tonicity 
in the renal medulla cause rapid production of large amounts of prostanoids. This 
ability of renal medullary cells may reflect the observed positive feedback loop of 
PGE2 on COX-2. 
 
The second section extended the previous observation that PGE2 increases COX-2 
expression in a positive feedback loop and focused on the underlying signaling 
pathway and its functional relevance. The stimulatory effect of PGE2 on COX-2 
abundance was not evident under isotonic conditions but could be demonstrated 
under osmotic stress at the mRNA and protein level, and by elevated COX-2 enzyme 
activity. The coupling of the prostanoid receptors to Gs-proteins and the existence of 
a CRE in the COX-2 promoter region suggested a corresponding signaling pathway. 
On the basis of pharmacological agonist- and inhibitor-based experiments, a PGE2-
21 
 
mediated signaling pathway was identified and involved the Gs-protein-coupled 
prostaglandin receptor EP2, subsequent increase of intracellular cAMP levels and 
activation of PKA. The effect of PGE2 was also consistently detectable in 
downstream signaling components. Activation of CREB with consequent increased 
transcription of COX-2-mRNA, enhanced CRE-driven reporter activity and stimulation 
of COX-2-promotor driven reporter activity by CRE-signaling could be demonstrated. 
The stimulatory effect of PGE2 on COX-2-promoter activity was abolished after site-
directed mutagenesis of the putative CRE-element. Additionally, a PGE2-EP2-cAMP-
PKA-mediated survival mechanism was detected. Phosphorylation of the 
proapoptotic protein Bad at serine residue 155 by PGE2-activated PKA, and hence 
inactivation of Bad, promoted cell survival and reduced caspase-3-activity. 
Pharmacological disruption of this pathway abolished the positive effect of PGE2 on 
cell survival and induced caspase activation under hypertonic conditions. 
 
In conclusion this study identified an EP2-cAMP-PKA-CREB-dependent signaling 
pathway that mediates a positive feedback mechanism of the major medullary 
prostaglandin PGE2 on COX-2 expression in response to osmotic stress. In addition 
PGE2 potentiated the expression of other osmoprotective genes. The study further 
demonstrated that PGE2 improved cell survival under hypertonic conditions 
substantially by EP2-cAMP-PKA-signaling via phosphorylation and inactivation of the 
proapoptotic protein Bad. The PGE2-dependent signaling pathway characterized here 
has functional importance for the adaptation of renal medullary cells to their hostile 
environment, for providing cell survival, and maintaining cell integrity. 
Pathophysiological relevance for the development of renal injury induced by non-
steroidal anti-inflammatory drugs (NSAID) appears conceivable.  
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Abstract 
 
The cells of the renal medulla produce large amounts of prostaglandin E2 (PGE2) via 
cyclooxygenases (COX)-1 and -2. PGE2 is well known to play a critical role in salt 
and water balance and maintenance of medullary blood flow. Since renal medullary 
PGE2 production increases in antidiuresis, and since COX inhibition is associated 
with damage to the renal medulla during water deprivation, PGE2 may promote the 
adaptation of renal papillary cells to high interstitial solute concentrations. To address 
this question, MDCK cells were exposed to a gradual tonicity increase in the 
presence or absence of 20 μm PGE2 prior to analysis of (i) cell survival, (ii) 
expression of osmoprotective genes (AR, BGT1, SMIT, HSP70 and COX-2), (iii) 
subcellular TonEBP / NFAT5 abundance, (iv) TonEBP / NFAT5 transcriptional 
activity and (v) aldose reductase promoter activity. Cell survival and apoptotic indices 
after raising the medium tonicity improved markedly in the presence of PGE2. PGE2 
significantly increased tonicity-mediated up-regulation of AR, SMIT and HSP70 
mRNAs. However, neither nuclear abundance nor TonEBP / NFAT5-driven reporter 
activity were elevated by PGE2, but aldose reductase promoter activity was 
significantly increased by PGE2. Interestingly, tonicity-induced COX-2 expression and 
activity was also stimulated by PGE2, suggesting the existence of a positive feedback 
loop. These results demonstrate that the major medullary prostanoid, PGE2, 
stimulates the expression of osmoprotective genes and favours the adaptation of 
medullary cells to increasing interstitial tonicities, an effect that is not explained 
directly by the presence of TonEs in the promoter region of the respective target 
genes. These findings may be relevant in the pathophysiology of medullary damage 
associated with analgesic drugs. 
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Introduction 
 
During antidiuresis, the cells of the renal medulla are exposed to a uniquely harsh 
environment, characterized by extreme concentrations of NaCl and urea, in addition 
to low oxygen tension (Brezis & Rosen, 1995; Neuhofer & Beck, 2005). Furthermore, 
during transition from diuresis to antidiuresis and vice versa, these cells are 
challenged by massive changes in interstitial solute concentrations. After stimulation 
of the urinary concentrating mechanism, renal papillary interstitial tonicity may double 
within a few hours (Beck et al. 1992). Specifically, it has been demonstrated that 
following intravenous administration of lysine-vasopressin, papillary tissue sodium 
concentration increases from approximately 140 to more than 300 mM within 2 h 
(Atherton et al. 1970). 
After tonicity increase, renal papillary cells initially shrink, thus leading to elevated 
concentration of intracellular electrolytes (i.e. the cellular ionic strength). The cells 
then activate volume regulatory mechanisms, which in turn allow restoration of cell 
volume, although intracellular ion concentrations remain elevated. A sustained rise in 
cellular ionic strength is, however, associated with DNA double-strand breaks and 
induces apoptosis in renal epithelial cells (Galloway et al. 1987; Kültz & Chakravarty, 
2001). In the longer term, medullary cells achieve osmotic equilibrium with the high 
interstitial solute concentrations by intracellular accumulation of small, non-perturbing 
organic compounds i.e. compatible osmolytes, including myo-inositol, sorbitol and 
betaine (Burg et al. 1997; Neuhofer & Beck, 2005). The elevated intracellular 
concentration of these substances predominantly results from increased uptake from 
the extracellular space (myo-inositol, betaine) or from intracellular synthesis 
(sorbitol). The proteins involved in intracellular osmolyte accumulation include the 
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sodium-dependent myo-inositol cotransporter-1 (SMIT1), the sodium- and chloride-
dependent betaine / GABA transporter-1 (BGT1), and aldose reductase (AR), which 
converts glucose to sorbitol. In addition, the expression of HSP70, a molecular 
chaperone expressed abundantly in the renal papilla (Cowley et al. 1995), is 
stimulated by tonicity stress and is believed to contribute to protection of medullary 
cells from the acute effects of hypertonicity (Neuhofer & Beck, 2005). The expression 
of the genes involved in osmolyte accumulation and that of HSP70 is stimulated by a 
common transcriptional activator, tonicity-responsive enhancer binding 
protein/nuclear factor of activated T cells-5 (TonEBP / NFAT5) (Woo et al. 2002a, b). 
The importance of this transcriptional activator for the cells of the renal medulla has 
been demonstrated in mice lacking TonEBP / NFAT5 (Lopez-Rodriguez et al. 2004). 
These animals show renal medullary atrophy as a result of reduced expression of 
tonicity-responsive genes (Lopez-Rodriguez et al. 2004). 
The action of cyclooxygenases (COX) in the renal medulla contributes importantly to 
the adaptation of medullary cells to their hostile environment. It has been well 
documented that prostanoids are important modulators of both medullary perfusion 
and tubular solute reabsorption, thereby linking tubular work to oxygen availability 
(Navar et al. 1996; Pallone et al. 2003; Neuhofer & Beck, 2005). In agreement, 
during antidiuresis, the renal medulla produces large amounts of prostaglandin E2 
(PGE2), most likely via COX-2, that is expressed constitutively in the renal medulla 
(Yang, 2003; Yang et al. 2005). COX inhibition by non-steroidal anti-inflammatory 
drugs (NSAID) has long been known to be associated with renal medullary injury, 
particularly in situations with stimulation of the renal concentrating mechanism 
(Schlöndorff, 1993; De Broe & Elseviers, 1998). Thus, the major medullary 
prostanoid, PGE2, may promote the adaptation of papillary cells to increasing 
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interstitial solute concentrations. This study aimed to address the question of whether 
PGE2 improves survival of medullary cells exposed to osmotic stress. 
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Methods 
 
Cell culture and experimental protocol 
Madin–Darby canine kidney (MDCK) cells were obtained from the American Type 
Culture Collection (ATCC CCL 34). The cells were maintained under standard 
conditions in Dulbecco's modified Eagles' medium (low glucose) containing 10% fetal 
bovine serum (FBS) and 1% penicillin / streptomycin. Two days prior to the 
experiments, the cells were plated in 60 mm, 35 mm (Greiner, Frickenhausen, 
Germany), or 24-well plates (Nunc, Roskilde, Denmark) and grown to confluence. 
Subsequently, the medium tonicity was gradually increased over 2 h in eight steps 
(addition of 25 mosmol (kg H2O)−1 NaCl every 15 min; final medium osmolality 500 
mosmol (kg H2O)−1). To elevate the medium tonicity to 700 mosmol (kg H2O)−1, 
osmolality was raised in 16 steps of 25 mosmol (kg H2O)−1 each by NaCl addition 
over 4 h. Tonicity increases were performed by adding the required volumes of a 4 m 
NaCl stock solution drop by drop to the dishes. Changes in pH and temperature as 
well as mechanical agitation were kept to a minimum. The isotonic control cells were 
treated accordingly, except that equal volumes of PBS were added to the cells, thus 
ruling out that the experimental procedure per se had negative effects on cell 
viability. Tonicity was increased either in the presence of 20 μm PGE2 (Sigma, 
Schnelldorf, Germany; dissolved as a 20 mm stock solution in ethanol) or the same 
volume of vehicle alone. Subsequently, the cells were processed as indicated. 
 
Northern blot analysis 
Following the treatments, the cells were lysed by the addition of TRI reagent (1 ml 
per 60 mm dish; PeqLab, Erlangen, Germany) and total RNA was recovered 
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according to the manufacturer's recommendations. Aliquots of 20 μg were 
electrophoresed through 1% agarose–formaldehyde gels, subsequently blotted onto 
positively charged nylon membranes (Roche, Mannheim, Germany) and immobilized 
by UV crosslinking as described elsewhere (Neuhofer et al. 2002). Relative mRNA 
abundance of the respective genes was monitored by hybridization with the following 
digoxigenin-labelled cDNAs: human AR (GenBank accession number J05474), 
canine SMIT1 (M85068), canine BGT1 (M80403), human inducible HSP70 
(M11717), bovine COX-2 (AF031698) and human glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH; X01677). Generation of non-radioactive, digoxigenin-
labelled probes, hybridization conditions and stringency washes are described in 
detail elsewhere (Neuhofer et al. 2002). Signals were subsequently quantified using 
Image J software (NIH, Bethesda, MA, USA) and the mRNA abundance of each 
individual gene was normalized to that of GAPDH to correct for differences in RNA 
loading. 
 
Determination of TonEBP/NFAT5 cytosolic and nuclear abundance 
Subcellular extracts were prepared with nuclear and cytosolic extraction reagents 
(NE-PER; Pierce, Rockford, IL, USA) according to the manufacturer's 
recommendations, with broad specificity protease inhibitor cocktail (Sigma) added at 
1:100 (v/v). Aliquots of 10 μg from each fraction were run subsequently on 8% SDS–
polyacrylamide gels and transferred to nitrocellulose membranes. After blocking non-
specific binding sites with blocking buffer (5% non-fat dry milk–0.1% Tween-20 in 
PBS) for 1 h, TonEBP / NFAT5 abundance was determined by incubation with 
TonEBP / NFAT5 antiserum (1:3000; Calbiochem, Darmstadt, Germany) in blocking 
buffer overnight at 4°C. Following washing with PBS–0.1% Tween-20 (3 x 5 min) and 
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incubation with horseradish peroxidase-conjugated goat anti-rabbit antibody (1: 10 
000 in blocking buffer, 1 h incubation at room temperature), bands were visualized by 
enhanced chemiluminescence (Pierce) and analysed using Image J software. 
 
Reporter gene assays 
For assessment of TonEBP transcriptional activity, a reporter construct based on 
secreted alkaline phosphatase (SEAP) (Berger et al. 1988) was prepared. SEAP is a 
truncated form of human placental alkaline phosphatase lacking the membrane 
anchoring domain. Thus, the truncated enzyme is secreted efficiently into the culture 
supernatant and SEAP activity in the supernatant is directly proportional to SEAP 
mRNA and protein abundance (Berger et al. 1988; Cullen & Malim, 1992). For 
generation of a TonE-driven SEAP construct, a DNA fragment containing two copies 
of the human TonE sequence with adjacent KpnI and Bgl II sites was prepared and 
inserted into the respective sites of pSEAP-control (Clontech, Mountain View, CA, 
USA), thereby adding the 2 x TonE sequence upstream from the SV40 early 
promoter. Subsequently, the 2 x TonE-SV40 early promoter fragment was released 
by KpnI and NruI and inserted into the respective sites of pSEAP-basic (Clontech). In 
the final construct, pSEAP-TonE, the SEAP-gene is preceded by two copies of the 
human TonE sequence and the SV40 early promoter, respectively (see also Fig. 6). 
To assess the effect of PGE2 in the context of a native promoter, a 1.5 kb fragment 
corresponding to nucleotides −1505 to +22 of the human aldose reductase promoter 
was amplified by PCR from genomic DNA from HEK 293 cells by PCR using primers 
5′-AGCT-CGAGCAAACCAACAACAAAGCCTC-3′ (forward) and 5′-GCAAGCTTCGC 
GTACCTTTAAATAGCCC-3′ (reverse), which introduced XhoI and HindIII sites to    
5′- and 3′- ends, respectively. The fragment was subsequently inserted into the 
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corresponding sites of pSEAP2-basic (Clontech). This region has been shown 
previously to confer osmotic inducibility and to contain at least one TonE (Ruepp et 
al. 1996; Nadkarni et al. 1999). The final construct, pSEAP-ARpro, was sequenced to 
verify orientation and sequence of the insert. 
For stable transfection of MDCK cells with the TonE construct, exponentially growing 
cells were transfected (5 μg DNA per 60 mm dish) using Effectene transfection 
reagent (Qiagen, Hilden, Germany) according to the manufacturer's 
recommendations. As pSEAP-2xTonE lacks eukaryotic selection markers, the cells 
were cotransfected with a 20:1 molar ratio of pSEAP-2xTonE and pcDNA3.1 
(containing a neomycin-resistance gene; Invitrogen, Karlsruhe, Germany). Following 
selection with 600 μg ml−1 geneticine, 40 stable clones were expanded and assessed 
for tonicity-inducible SEAP activity (see below). Several healthy clones with highly 
tonicity-inducible SEAP activity were subsequently pooled and used for experiments 
at passages 3–6 (in the following denoted as MDCK-pSEAP-TonE). 
To assess the effect of PGE2 on TonEBP transcriptional activity under hypertonic 
conditions, MDCK-pSEAP-TonE cells were seeded in a 24-well plate 2 days prior to 
the experiment at a density to reach confluence within 2 days. Prior to the 
experiments, the medium (1 ml DMEM without phenol red lacking G418 per well) was 
refreshed and the cells were exposed to a gradual tonicity increase to 500 mosmol 
kg−1 as described above. After the indicated periods, 50 μl medium was removed and 
stored in 96-well plates at −80°C for further analysis. Prior to determination of SEAP 
activity, the 96-well plates containing the conditioned medium were sealed and 
incubated for 45 min in a water bath at 65°C to inactivate endogenous alkaline 
phosphatase activity, since SEAP is extremely heat stable (Cullen & Malim, 1992). 
Subsequently, 150 μl p-nitrophenyl phosphate liquid substrate (Sigma) was added 
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and the mixture incubated for 1–2 h at room temperature. Finally, SEAP activity was 
assessed at 405 nm in a microplate reader. 
Transient transfections were performed in 24-well plates at 50–75% cell confluence 
with a 3:1 molar ratio of pSEAP-ARpro and pcDNA3-LacZ using Effectene 
transfection reagent according to the manufacturer's instructions. After 24 h, the cells 
were used for experiments, and SEAP activity was determined as described above 
and subsequently normalized to that of β-galactosidase. Briefly, cells were washed 
with PBS and lysed in situ by vigorous shaking for 5 min after the addition of 135 μl 
TBS–0.1% Triton X-100, followed by two freeze–thaw cycles. Then, 600 μl β-
galactosidase substrate was added per well (0.1 mm chlorophenol red-beta-d-
galactopyranoside (Roche, Mannheim, Germany) in 100 mm potassium phosphate 
buffer, pH 7.5, containing 2 mm DTT and 1 mm MgCl2). The reaction was incubated 
for 2–4 h at room temperature and finally read at 574 nm. 
 
Assessment of cell survival 
After the respective treatments, detached cells were aspirated, adherent cells were 
collected by trypsinization, and cell numbers in both fractions were counted in a 
haemocytometer. The surviving fraction was expressed as the adherent/total 
(adherent plus detached) cell ratio as previously described (Neuhofer et al. 2001). 
Determination of lactate dehydrogenase (LDH) release 
Following the respective treatments, a small aliquot of medium was removed and 
adherent cells were then collected and disrupted by repeated vigorous passage 
through a 26-gauge needle. LDH activity was determined using a commercially 
available assay and expressed as the ratio between the activities in the supernatant 
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and total LDH activity (supernatant plus adherent) as previously described (Neuhofer 
et al. 2001). 
 
Determination of caspase-3 activity 
Caspase-3 activity was assessed using an assay based on the cleavage of a 
synthetic, p-nitroanilin-conjugated caspase-3 substrate (Asp-Glu-Val-Asp; CaspACE 
Assay System; Promega, Madison, WI, USA). Briefly, cells in 35-mm dishes were 
washed with ice-cold PBS after the indicated treatments and disrupted by the 
addition of 100 μl lysis buffer. After three freeze–thaw cycles, the lysates were 
cleared by centrifugation at 12000 g at 4°C for 20 min. Caspase-3 activity was 
monitored in 10 μl aliquots from the supernatant by an increase in absorbance at 405 
nm according to the manufacturer's recommendations, and was referred 
subsequently to the protein concentration in the cell lysates. Relative caspase-3 
activity is expressed as nanomoles of p-nitroanilin released per milligram of protein in 
1 h. 
 
Determination of COX activity 
COX activity in lysates of MDCK cells was assessed using a commercially available 
assay (COX activity assay kit; Cayman Chemicals, Ann Arbor, MI, USA) based on 
the colourimetric measurement of the peroxidase activity of cyclooxygenase by 
monitoring the formation of oxidized N,N,N′,N′-tetramethyl-p-phenylendiamine 
(TMPD) at 620 nm. Briefly, cells were washed with ice-cold TBS and harvested in 
200 μl TBS containing 1 mm EDTA and 1% (v/v) protease inhibitor cocktail (Sigma), 
and lysed mechanically by repeated vigorous passage through a 26-gauge needle. 
Subsequently, the lysate was cleared by centrifugation at 12000 g for 15 min at 4°C 
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and COX activity was assessed on equal volumes of the supernatant according to 
the recommendations of the manufacturer. To distinguish COX-2 from COX-1 
activity, the samples were compared to a corresponding one containing an 
isoenzyme-specific inhibitor for COX-2 and COX-1, respectively (DuP-697, SC-560; 
300 nm final concentration each). Subsequently, COX activity was normalized to the 
protein concentration in the lysates and expressed as U (μg of protein)−1. 
 
Measurement of intracellular electrolytes 
MDCK cells were grown on collagen-coated filter membranes (Millicell-CM; Millipore, 
Bedford, MA, USA). At the end of the experiments, the medium was removed rapidly 
and the filters covered with a standard albumin solution applied on both apical and 
basal sides and snap frozen in a mixture of propane and isopentane (3:1 v/v; 
−196°C) as described elsewhere (Beck et al. 1992; Neuhofer et al. 2002). The 
standard albumin solution was prepared by dissolving 2 g bovine serum albumin in 
10 ml of the respective medium. Cryosections (1 μm) were cut at −80°C using an 
ultracryomicrotome (LKB, Bromma, Sweden). The cryosections were then freeze-
dried and analysed in a scanning electron microscope equipped with an X-ray 
detector system as described in detail elsewhere (Beck et al. 1992). Intracellular 
electrolyte concentration is expressed as mmol (kg wet weight)−1. 
 
Statistical analyses 
Data are expressed as means ±s.e.m. The significance of differences between the 
means was assessed by Student's t test. P < 0.05 was regarded as significant. 
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Results 
 
Effect of PGE2 on survival of MDCK cells under hypertonic conditions 
To determine whether PGE2 enhances cell survival under osmotic stress, MDCK 
cells were subjected to a gradual tonicity increase to 700 mosmol (kg H2O)−1 by NaCl 
addition over a period of 4 h in the presence of 20 μm PGE2 or only vehicle ethanol. 
Comparable tonicity increases have been observed in the papilla of the mammalian 
kidney in vivo 2–4 h following acute stimulation of the urinary concentrating 
mechanism (Atherton et al. 1971). As the interstitial tonicity rises continuously over 
several hours after stimulation of the urinary concentrating mechanism, in the present 
experiments a nearly linear osmolality increase was employed to mimic more closely 
the situation in the renal medulla in situ compared with a single step increase. 
Since hypertonicity induces apoptosis in non-protected cells, the effect of PGE2 on 
tonicity-induced caspase-3 activation was measured. As shown in Fig. 1, caspase-3 
activity time-dependently increased after elevating the medium tonicity in the 
absence of PGE2. However, when PGE2 was present from the beginning of the 
tonicity increase, caspase-3 activity remained at levels not different from isotonic 
controls, indicating protection from tonicity-induced apoptosis by PGE2. The same 
effect was evident when markers of cell damage were assessed. As shown in Fig. 
2A, the vast majority of cells detached 20 h after the tonicity increase in the absence 
of PGE2. In the presence of PGE2, however, the cell monolayer remained largely 
intact (Fig. 2C). Accordingly, PGE2 significantly prevented LDH release into the 
medium after elevating the medium osmolality (Fig. 2B).  
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Effect of PGE2 on expression of osmoprotective genes 
To determine whether protection against tonicity-induced cell damage by PGE2 is 
associated with enhanced expression of osmoprotective genes, mRNA abundance of 
several osmosensitive genes was determined. As demonstrated in Fig. 3, SMIT1, AR 
and BGT1 mRNA abundance increased time dependently in MDCK cells after raising 
the medium osmolality. Up-regulation of SMIT and BGT1 preceded that of AR. 
Addition of PGE2 further enhanced SMIT and AR mRNA expression, but interestingly, 
not that of BGT1. 
In addition to genes involved in osmolyte accumulation, two other genes with 
osmoprotective functions, HSP70 and COX-2, were also assessed. As shown in Fig. 
3, tonicity-induced up-regulation of HSP70 mRNA was more transient and declined 
with increased expression of AR, BGT1 and SMIT. In the presence of PGE2, 
induction of HSP70 was significantly enhanced. Interestingly, tonicity-induced COX-2 
mRNA abundance was further enhanced, suggesting the presence of a positive 
feedback loop. 
 
Effect of PGE2 on COX activity 
As shown in Fig. 3, induction of COX-2 mRNA in response to osmotic stress was 
further enhanced in the presence of PGE2, suggesting the presence of a positive 
feedback loop. This phenomenon was also evident at the protein level (not shown). 
To assess whether these effects on COX-2 abundance are accompanied by parallel 
changes in COX-2 activity, the latter was determined in lysates from cells exposed to 
osmotic stress in the presence or absence of 20 μm PGE2. As shown in Fig. 4A, 
hypertonicity significantly increased COX activity, which was further stimulated about 
threefold by PGE2. Addition of DuP-697 (300 nM), a COX-2 specific inhibitor, to the 
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reaction reduced total COX activity by about 50%, whereas inclusion of SC-560 (300 
nM), a COX-1 specific inhibitor, had only minor effects on COX activity, indicating 
that COX-2 accounts for the vast majority of COX activity and that COX-2 is indeed 
positively regulated by PGE2 in response to hypertonicity at the functional level. 
 
Effect of PGE2 on TonEBP / NFAT5 transcriptional activity 
Following osmotic stress, expression of AR, BGT1, SMIT and HSP70 is stimulated by 
a common transcriptional activator, TonEBP / NFAT5. We therefore determined in 
the next step, whether the enhanced expression of AR, SMIT and HSP70 in the 
presence of PGE2 is related to increased TonEBP / NFAT5 activity. 
Enhanced expression and translocation of TonEBP / NFAT5 from the cytosol to the 
nucleus represents an important mechanism regulating TonEBP / NFAT5 
transcriptional activity (Cha et al. 2001). Therefore, nuclear and cytosolic fractions 
were prepared at different times after the tonicity increase in the presence or 
absence of PGE2. As demonstrated in Fig. 5, TonEBP / NFAT5 accumulated rapidly 
in the nucleus following osmotic stress; however, this translocation was not affected 
by PGE2. In cytosolic fractions, TonEBP / NFAT5 abundance was also not different. 
Likewise, total TonEBP / NFAT5 expression in whole cell lysates was equal in PGE2 
and vehicle-treated cells (not shown). We can, however, not rule out the possibility 
that changes in TonEBP / NFAT5 transactivation activity, an important mechanism 
regulating TonEBP / NFAT5 activity (Ferraris et al. 2002), are affected by PGE2, 
because this parameter was not assessed in the present study. 
TonEBP / NFAT5 reporter activity was then assessed in MDCK cells stably 
transfected with a TonE-SEAP construct following osmotic stress in the presence and 
absence of PGE2. As demonstrated in Fig. 6, TonE-driven SEAP expression time 
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dependently increased after raising the medium osmolality. This response was, 
however, not further enhanced by PGE2. To assess the effect of PGE2 in the context 
of a native promoter, additional reporter gene assays were performed using a 1.5 kb 
fragment of the AR promoter (Fig. 7). In contrast to the results obtained with the 
TonE-driven construct, PGE2 significantly stimulated AR promoter-driven reporter 
activity in response to an increase in tonicity. In aggregate, these data indicate that 
the presence of TonEs is not sufficient to explain the effect of PGE2 on AR promoter 
activity and on the expression of osmoprotective genes. Putative, yet unidentified, 
factors probably contribute. 
 
Effect of PGE2 on intracellular electrolytes 
In cells exposed to osmotic stress, the intracellular concentration of monovalent ions 
is increased substantially in the initial phase. Subsequently, intracellular electrolytes 
are continuously replaced by metabolically neutral organic osmolytes, a process 
requiring up to several days. To assess whether PGE2 affects cellular ionic strength 
(which is determined largely by the sum of intracellular Na+, Cl− and K+ 
concentrations), MDCK cells were exposed to a gradual tonicity increase to 700 
mosmol (kg H2O)−1 over 4 h. After an additional 6 h at 700 mosmol (kg H2O)−1, 
intracellular electrolytes were determined by electron microprobe analysis. Since 
progressive cell detachment occurs after 6 h at 700 mosmol (kg H2O)−1 in the 
absence of PGE2, extension of the observation period was not feasible. As shown in 
Fig. 8, cellular ionic strength was elevated substantially after 6 h in MDCK cells 
exposed to a gradual tonicity increase to 700 mosmol (kg H2O)−1, both in the 
presence of PGE2 or vehicle as compared with cells kept in isotonic medium        
(300 mosmol (kg H2O)−1). Although intracellular concentrations of Na+ and Cl− were 
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less in the presence of PGE2, those of K+ were higher than in vehicle-treated cells, 
thus resulting in comparable cellular ionic strength. The results suggest that organic 
osmolytes have not been accumulated in significant amounts after 6 h, and that 
enhanced expression of HSP70 may be more relevant for cytoprotection by PGE2. 
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Discussion 
 
Analgesic drug-induced nephropathy accounts for a significant proportion of patients 
with chronic renal failure (De Broe & Elseviers, 1998). Even short-term use of these 
compounds may result in impaired renal function, in particular when accompanied by 
dehydration (Schlöndorff, 1993; De Broe & Elseviers, 1998; Kovacevic et al. 2003). 
This phenomenon has been traditionally ascribed to an imbalance between 
medullary vasoconstrictors (i.e. angiotensin II, arginine–vasopression, endothelin and 
others) to medullary vasodilators (i.e. nitric oxide, prostacyclin, PGE2), thus resulting 
in hypoxic damage of medullary cells (Schlöndorff, 1993; Brezis & Rosen, 1995). In 
particular, the production of the latter two substances is impeded by NSAIDs, 
indicating that prostanoids may contribute decisively to the survival of medullary cells 
in conditions associated with stimulation of the urinary concentrating mechanism. 
During antidiuresis, the renal inner medulla is not only chronically hypoxic, but is also 
characterized by extreme interstitial solute concentrations (Neuhofer & Beck, 2005). 
It is thus conceivable that medullary prostanoids not only improve medullary oxygen 
balance but also favour the adaptation of medullary cells to high interstitial solute 
concentrations. In agreement, PGE2, the major medullary prostanoid, is produced in 
large amounts in the renal medulla during antidiuresis (Breyer & Breyer, 2001; Yang, 
2003). 
Indeed, the present observations clearly demonstrate that PGE2 promotes survival of 
MDCK cells exposed to osmotic stress, which coincided with enhanced expression of 
osmoprotective genes (SMIT, AR, HSP70). In the present experiments, extracellular 
tonicity was raised almost linearly over several hours, an approach which more 
closely resembles the situation in the renal papilla in situ, than does a one-step 
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elevation that has been employed in most experimental models to date. A 
comparable increase in interstitial tonicity has been reported in the papilla of the 
mammalian kidney in vivo following acute stimulation of the urinary concentrating 
mechanism (Atherton et al. 1971). Enhanced cell survival has been directly 
demonstrated following a gradual increase in osmolality (Cai et al. 2002). In contrast 
to a step increase, cells exposed to a gradual tonicity increase are unlikely to show a 
significant reduction in cell volume by virtue of the concurrent operation of volume 
regulatory mechanisms, a situation known as isovolumetric regulation (Lohr & 
Grantham, 1986). This is achieved by gradual uptake of electrolytes from the 
extracellular space and intracellular accumulation of organic osmolytes with 
increasing extracellular osmolality and osmotically obliged water entry, thus allowing 
maintenance of cell volume (Rome et al. 1989). Nonetheless, both a step and a 
gradual tonicity increase are associated with a rise in cellular ionic strength, which 
exerts adverse effects on cell viability, including DNA double strand breaks and 
induction of apoptosis (Galloway et al. 1987; Kültz & Chakravarty, 2001). In the 
longer term, renal medullary cells both in vivo and in vitro adapt to elevated 
extracellular solute concentrations by the accumulation of osmotically active, non-
perturbing organic osmolytes, which replace intracellular ions. In conjunction with 
osmotic changes, there is enhanced expression of cytoprotective heat shock 
proteins, mainly HSP70 (Cohen et al. 1991; Neuhofer & Beck, 2005). 
The accumulation of significant amounts of organic osmolytes is, however, a 
relatively slow process, requiring up to several days. In agreement, in the present 
experiments, cellular ionic strength 6 h after a gradual tonicity increase was elevated 
to comparable levels in the presence of PGE2 or vehicle. These observations argue 
against the accumulation of significant amounts of organic osmolytes in this early 
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phase. Nevertheless, caspase-3 activation at this time is completely prevented by 
PGE2 and cell survival is strongly enhanced after 20 h (Figs 1 and 2). As shown in 
Fig. 3, induction of HSP70 precedes that of SMIT and AR, suggesting that HSP70 
may protect medullary cells in a situation in which compatible osmolytes are not yet 
present in sufficient amounts. In agreement, HSP70 potently blocks apoptosis at 
several levels, including direct interaction with caspase-3, thus impairing the 
execution of the apoptotic pathway (Ravagnan et al. 2001; Komarova et al. 2004). In 
addition to the increased mRNA abundance of HSP70 in the presence of PGE2, 
HSP70 was also induced more vigorously at the protein level when the hypertonic 
medium was supplemented with PGE2 (not shown). Thus, in the early phase of 
osmotic stress, HSP70 may be important for cell survival. 
Tonicity-stimulated expression of AR, BGT1, SMIT and HSP70 has been 
demonstrated to be mediated by TonEBP / NFAT5 (Woo et al. 2002 a, b). Although 
the activity of TonEBP / NFAT5 is required for tonicity-induced expression of 
osmoprotective genes (Na et al. 2003; Lopez-Rodriguez et al. 2004), the present 
data demonstrate enhanced expression of AR, SMIT, HSP70 and COX-2 in the 
presence of PGE2 in the absence of increased nuclear abundance or elevated TonE-
driven reporter activity. Nevertheless, PGE2 significantly increased reporter activity in 
experiments using a 1.5 kb fragment of the AR promoter. These data indicate that 
the presence of TonEs is not sufficient to explain the effect of PGE2 on AR promoter 
activity and expression of osmoprotective genes. Probably, additional signalling 
events and transcriptional activators modulate the expression of osmoprotective 
genes, possibly via cooperative effects on TonEBP. This assumption is supported 
further by the lack of stimulation of BGT1 expression. Divergent pathways regulating 
the expression of SMIT and BGT1 have already been previously described (Atta et 
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al. 1999). Additionally, tonicity-induced expression of COX-2 was also markedly 
stimulated by PGE2, although COX-2 is not a known TonEBP / NFAT5 target gene 
(Yang, 2003), further supporting the view that the stimulatory effect of PGE2 is not 
directly mediated via enhanced TonEBP-TonE signalling. 
In summary, PGE2 promotes survival of MDCK cells exposed to osmotic stress, 
which occurred in parallel with enhanced expression of osmoprotective genes. The 
latter effect appears, however, not to be directly mediated by increased 
transcriptional activity of TonEBP / NFAT5. Tonicity-induced expression of COX-2 
and activity was further stimulated by PGE2, indicating the existence of a positive 
feedback loop. This observation may reflect the requirement for the rapid production 
of PGE2 after stimulation of the urinary concentrating mechanism. Thus, elevated 
PGE2 concentrations during antidiuresis may not only help to prevent hypoxic injury 
to medullary cells, but also to promote osmoadaptation. The present concept that 
PGE2 promotes osmoadaptation of medullary cells is in good agreement with the 
observation that COX inhibition may be associated with renal papillary injury in vivo 
(Moeckel et al. 2003; Neuhofer et al. 2004), particularly when accompanied by 
dehydration. 
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Legends for figures 
 
Figure  1. Effect of prostaglandin E2 (PGE2) on tonicity-induced caspase-3 activation. 
MDCK cells were exposed to a gradual tonicity increase to 700 mosmol (kg H2O)−1 
over 4 h by NaCl addition in the presence of 20 μM PGE2 (NaCl + PGE2) or vehicle 
ethanol (NaCl + vehicle). At the times indicated after reaching the final osmolality of           
700 mosmol (kg H2O)−1, relative caspase-3 activity was determined as described in 
the Methods. Means±SEM for n=4-6; *P<0.05 vs. NaCl + PGE2. 
 
Figure  2. Effect of PGE2 on cell survival of MDCK cells under hypertonic conditions. 
MDCK cells were exposed to a gradual tonicity increase to 700 mosmol (kg H2O)−1 
over 4 h by NaCl addition in the presence of 20 μM PGE2 (NaCl + PGE2) or vehicle 
ethanol (NaCl + vehicle). Twenty hours after reaching the final osmolality of 700 
mosmol (kg H2O)−1, cell survival was assessed. (A) Percentage of surviving cells 
determined as described in Methods. Means±SEM for n=4; * P<0.05 vs. NaCl + 
vehicle. (B) Lactate dehydrogenase (LDH) release expressed as percentage of total 
LDH activity of the respective cultures. Means±SEM for n=4; * P<0.05 vs. NaCl + 
vehicle. (C) Representative phase contrast micrographs of the cells remaining 
attached to the culture dish 20 h after tonicity increase. 
 
Figure  3. Effect of PGE2 on expression of osmoprotective genes in MDCK cells 
under hypertonic conditions.  
MDCK cells were exposed to a gradual tonicity increase to  500 mosmol (kg H2O)−1 
by NaCl addition in the presence of 20 μM PGE2 (NaCl + PGE2) or vehicle ethanol 
(NaCl + vehicle), or were kept in isotonic medium (iso). The expression of the 
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respective genes (SMIT, sodium myo-inositol cotransporter-1; AR, aldose reductase; 
BGT1, betaine/GABA transporter-1; HSP70, heat shock protein 70; COX-2, 
cyclooxygenase-2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase) was 
determined at the times indicated after reaching the final osmolality of 500 mosmol 
(kg H2O)−1 by Northern blot analysis. (A) Relative mRNA abundance was normalized 
to that of GAPDH. Means±SEM for n=4; *P<0.05 vs. NaCl + vehicle. (B) 
Representative Northern blots. 
 
Figure  4. Effect of PGE2 on COX activity in MDCK cells exposed to osmotic stress. 
MDCK cells were exposed to a gradual tonicity increase to 500 mosmol (kg H2O)−1 
by NaCl addition in the presence of 20 μM PGE2 (NaCl + PGE2) or vehicle ethanol 
(NaCl + vehicle), or were kept in isotonic medium (iso). (A) After 24 h, COX activity 
was determined as described in "Methods". Means±SEM for n=4; *P<0.05 vs. iso; 
#P<0.05 vs. NaCl + Vehicle. (B) The contribution of COX-1 and COX-2 isoforms to 
total COX activity in lysates from cells treated with NaCl in the presence of PGE2 was 
assessed by addition of COX-1 (SC-560) and COX-2 (Du-P697) specific inhibitors, 
respectively. Means±SEM for n=4. 
 
Figure  5. Effect of PGE2 on nuclear and cytosolic abundance of tonicity-responsive 
enhancer binding protein/nuclear factor of activated T cells-5 (TonEBP / NFAT5) 
under hypertonic conditions.  
MDCK cells were exposed to a gradual tonicity increase to  500 mosmol (kg H2O)−1 
by NaCl addition in the presence of 20 μM PGE2 (NaCl + PGE2) or vehicle ethanol 
(NaCl + vehicle), or were kept in isotonic medium (iso). At the times indicated after 
reaching the final osmolality of 500 mosmol (kg H2O)−1, nuclear and cytosolic 
69 
 
fractions were prepared and relative TonEBP / NFAT5 abundance within each 
fraction was determined by Western blot analysis. Means±SEM for n=3-4. 
 
Figure  6. Effect of PGE2 on TonE-driven reporter activity.  
MDCK cells were stably transfected with a TonE-driven secreted alkaline 
phosphatase (SEAP) reporter construct. Subsequently, the cells were exposed to a 
gradual tonicity increase to 500 mosmol (kg H2O)−1 by NaCl addition in the presence 
of 20 μM PGE2 (NaCl + PGE2) or vehicle ethanol (NaCl + vehicle), or were kept in 
isotonic medium (iso). Relative SEAP activity in the cell culture supernatant was 
assessed at the indicated time points as described in Methods. Means±SEM for n=4-
8; *P<0.05 vs. iso. 
 
Figure  7. Effect of PGE2 on aldose reductase promoter activity.  
MDCK cells were transiently transfected with a 1,5 kb aldose reductase promoter-
driven secreted alkaline phosphatase (SEAP) reporter construct. Subsequently, the 
cells were exposed to a gradual tonicity increase to 500 mosmol (kg H2O)−1 by NaCl 
addition in the presence of 20 μM PGE2 (NaCl + PGE2) or vehicle ethanol (NaCl + 
vehicle), or were kept in isotonic medium (iso). Relative SEAP activity in the cell 
culture supernatant was assessed 24 h after tonicity increase as described in 
"Methods". Means±SEM for n=6. *P<0.05 vs. iso ; #P<0.05 vs. NaCl + Vehicle. 
 
Figure  8. Effect of PGE2 on intracellular electrolyte concentrations in MDCK under 
hypertonic conditions.  
MDCK cells were exposed to a gradual tonicity increase to 700 mosmol (kg H2O)−1 
by NaCl addition in the presence of 20 μM PGE2 (NaCl + PGE2) or vehicle ethanol 
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(NaCl + vehicle), or kept in isotonic medium (iso). Then, 6 h after reaching the final 
osmolality of 700 mosmol (kg H2O)−1, intracellular concentrations of Na+, Cl- and K+ 
were determined by electron microprobe analysis. The number of intracellular 
measurement (N) is indicated. *P<0.05 vs. iso ; ‡P<0.05 vs. NaCl + Vehicle for Na+ 
and K+. 
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Abstract 
 
Cyooxygenase-2 (COX-2)-derived PGE2 is critical for the integrity and function of 
renal medullary cells during antidiuresis. The present study extended our previous 
finding that tonicity-induced COX-2 expression is further stimulated by the major 
COX-2 product PGE2 and investigated the underlying signaling pathways and the 
functional relevance of this phenomenon. Hyperosmolality stimulated COX-2 
expression and activity in Madin-Darby canine kidney (MDCK) cells, a response that 
was further increased by PGE2-cAMP signaling, suggesting the existence of a 
positive feedback loop. This effect was diminished by AH-6809, an EP2 antagonist, 
and by the PKA inhibitor H-89, but not by AH-23848, an EP4 antagonist. The effect of 
PGE2 was mimicked by forskolin and dibutyryl-cAMP, suggesting that the stimulatory 
effect of PGE2 on COX-2 is mediated by a cAMP-PKA-dependent mechanism. 
Accordingly, cAMP-responsive element (CRE)-driven reporter activity paralleled the 
effects of PGE2, AH-6809, AH-23848, H-89, forskolin, and dibutyryl-cAMP on COX-2 
expression. In addition, the stimulatory effect of PGE2 on tonicity-induced COX-2 
expression was blunted in cells transfected with dominant-negative CRE binding 
(CREB) protein, as was the case in a COX-2 promoter reporter construct in which a 
putative CRE was deleted. Furthermore, PGE2 resulted in PKA-dependent 
phosphorylation of the pro-apoptotic protein Bad at Ser155, a mechanism that is 
known to inactivate Bad, which coincided with reduced caspase-3 activity during 
osmotic stress. Conversely, pharmacological interruption of the PGE2-EP2-cAMP-
PKA pathway abolished Ser155 phosphorylation of Bad and blunted the protective 
effect of PGE2 on cell survival during osmotic stress. These observations indicate the 
existence of a positive feedback loop of PGE2 on COX-2 expression during osmotic 
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stress, an effect that apparently is mediated by EP2-cAMP-PKA signaling, and that 
contributes to cell survival under hypertonic conditions.  
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Introduction 
 
The interstitial environment of the renal medulla is characterized by extremely high 
interstitial osmolalities and low oxygen tension (34). Nevertheless, medulla-resident 
cells not only have the ability to survive in this hostile environment but also to 
function normally. This feature is of integral importance for maintaining the kidneys' 
function in regulating systemic electrolyte and fluid homeostasis.  
A characteristic feature of renal medullary cells is their high capacity for production of 
prostaglandins (PG) (4). PGs are autacoids acting close to their site of formation and 
contribute essentially to the regulation of tubular solute and water reabsorption and 
adjusting medullary blood flow to metabolic requirements (12, 32, 34). Moreover, 
PGs promote the adaptation of renal medullary cells to high extracellular osmolalities 
by virtue of enhancing the expression of osmoprotective genes (29, 35, 37). The 
formation of PGs depends on the sequential action of cytosolic phospholipase A2 
(cPLA2), which releases arachidonic acid from membrane phospholipids, and 
cyclooxygenase (COX) (30). The direct metabolite of arachidonic acid formed by 
COX is PGH2, which is then converted to various biologically active prostanoids. At 
least two different COX isoforms have been described; these share the same 
enzymatic properties but differ substantially in their amino acid sequence and mode 
of regulation. In contrast to most other tissues, COX-2 is expressed constitutively in 
the renal medulla, is further upregulated during dehydration, and is assumed to 
account for the majority of prostanoids formed in the renal medulla under this 
condition (7, 49). Among the various prostanoids, PGE2 accounts quantitatively for 
the vast majority of PGs formed in the renal medulla (4). Four PGE2 receptor 
subtypes, designated EP1 to EP4, mediate the biological effects of PGE2. Activation 
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of EP1 causes mobilization of Ca2+, while EP3 is coupled to Gαi, thereby inhibiting 
intracellular cAMP formation (31). Both EP2 and EP4 are linked to Gαs, which results 
in enhanced cAMP levels upon receptor stimulation (31).  
In the renal papilla in vivo, COX-2 is robustly induced by arginine vasopressin (AVP) 
administration as well as by dehydration, and COX-2 abundance closely correlates 
with urine osmolality (49, 51). Further studies have demonstrated that the enhanced 
expression of COX-2 during antidiuresis is not mediated directly by AVP but occurs 
secondarily in response to a rise in medullary interstitial tonicity (49, 51). In contrast 
to other osmosensitive genes, COX-2 is not regulated by tonicity-responsive 
enhancer binding protein/nuclear factor of activated T cells 5 (TonEBP/NFAT5), 
which drives the expression of several genes required for both efficient urinary 
concentration and osmoadaptation of renal medullary cells (46). The importance of 
enhanced COX-2 expression and PGE2 production under hypertonic conditions is 
underscored by the fact that COX-2 induction precedes that of other osmoprotective 
genes during osmotic stress (37). Consistent with this notion, diminished COX-2 
expression or selective inhibition of COX-2 is associated with damage of renal 
medullary cells in vivo and in vitro following a rise in ambient tonicity (13, 29, 35). 
Thus the rapid induction of COX-2 and subsequent production of PGE2 appears to be 
of critical importance for efficient osmoadaptation of renal medullary cells. In the 
renal papilla in vivo, interstitial tonicity may increase two- to threefold within 2–4 h 
after acute stimulation of the urinary concentrating mechanism (1). Comparable 
increases in osmolality, however, cause apoptosis in cultured medullary cells, while 
PGE2 confers protection when added to the medium (25, 37). PGE2 has been 
demonstrated to exert anti-apoptotic effects, which are mediated by EP2 and EP4 
receptors, in various cell types (2, 6, 42).  
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We have previously observed that PGE2 enhances the expression of various 
osmoprotective genes and, interestingly, also that of COX-2 under hypertonic 
conditions, suggesting the existence of a positive feedback loop. This is consistent 
with a previous study by Sonoshita et al. (41) who demonstrated stimulation of COX-
2 expression in an EP2 receptor, PKA- dependent manner in a murine intestinal 
polyposis model (41). It thus appears possible that PGE2 potentiates the induction of 
COX-2 during osmotic stress in an auto-/paracrine manner, thereby further 
increasing PGE2 production in a positive feedback loop. This mechanism would, in 
turn, favor cell survival by antagonizing pro-apoptotic signaling pathways that are 
activated during acute osmotic stress. The aim of the present study was thus to 
extend our previous findings with focus on the signaling pathways and to address the 
functional significance in Madin-Darby canine kidney (MDCK) cells as a model 
system for renal medullary cells.  
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Methods 
 
Cell culture and experimental protocol. 
MDCK cells were obtained from the American Type Culture Collection (ATCC; CCL 
34). The cells were grown under standard conditions in Dulbecco's Modified Eagles 
Medium (DMEM) (low glucose) containing 10% fetal bovine serum (FBS) and 1% 
penicillin-streptomycin. For experiments, the cells were plated in 80-mm, 35-mm 
(Greiner, Frickenhausen, Germany), or 24-well plates (Nunc, Roskilde, Denmark). 
After confluence was reached, medium tonicity was increased to the indicated final 
osmolality by adding the required volume of 4 M NaCl drop by drop to the dishes. To 
achieve a quasilinear, gradual increase in the medium tonicity, the latter was 
elevated in 10 steps of 40 mosmol/kg H2O each over a period of 4 h to a final 
osmolality of 700 mosmol/kg H2O. In experiments with pharmacological inhibitors, the 
respective compound was added at the indicated concentration from concentrated 
stock solutions 30 min before tonicity increase, or, as a control, the same volume of 
vehicle was added. Stock solutions were prepared as following: AH6809 (10 mM in 
DMSO; Sigma, Schnelldorf, Germany), AH23848 (30 mM in DMSO; Sigma), and H-
89 (20 mM in DMSO; Sigma). In experiments with PGE2 (10 mM stock in ethanol; 
Sigma), forskolin (1 mM stock in ethanol; Sigma), or dibutyryl-cAMP (1 M stock in 
H2O; Roche Diagnostics, Indianapolis, IN), the respective agonist or the same 
volume of vehicle was added at the time of tonicity increase.  
 
Western blot analysis. 
For detection of COX-2 and actin, cells were washed with ice-cold PBS and lysed in 
8 M urea-PBS (75 μl / 35-mm plate) and centrifuged at 13,000 g for 15 min at 4°C. 
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For immunodetection of Bad and phospho-Bad-Ser155, the cells in 35-mm dishes 
were washed with ice-cold Tris-buffered saline (TBS), incubated for 5 min on ice in 
50 μl lysis buffer containing (in mM) 20 Tris·HCl, pH 7.5, 150 NaCl, 1 EDTA, 1 EGTA, 
1% (vol/vol) Triton X-100, 1% (vol/vol) broad spectrum protease inhibitor cocktail 
(Sigma), and 1% (vol/vol) phosphatase inhibitor cocktail 2 (Sigma). Thereafter, the 
cells were collected with a rubber policeman, sonicated four times for 5 s on ice, and 
centrifuged at 13000 g for 10 min at 4°C.  
Protein concentration in the supernatants was determined using a commercially 
available assay (Bio-Rad, Hercules, CA) and aliquots of 20 μg (COX-2, actin) or 
aliquots of 80 μg (Bad, phospho-Bad) of protein were separated on 10% (COX-2, 
actin) or 12% (Bad, phospho-Bad) SDS gels and subsequently transferred to 
nitrocellulose membranes (Hybond; Amersham, Freiburg, Germany). For COX-2 and 
actin staining, nonspecific binding sites were blocked by incubation in blocking buffer 
(5% nonfat dry milk in PBS containing 0.1% Tween-20). COX-2 abundance was 
determined by incubation with rabbit polyclonal anti-COX-2 antibody (1:5000 in 
blocking buffer; Cayman Chemicals, Ann Arbor, MI) at 4°C overnight. Actin was 
stained by incubation with rabbit polyclonal anti-actin antibody (1:5,000 in blocking 
buffer; 1 h at room temperature; Sigma). Expression of EP2 and cAMP responsive 
element (CRE) binding (CREB) was monitored by rabbit polyclonal anti-EP2 (1:1,000 
in blocking buffer; Santa Cruz Biotechnology;) and by rabbit polyclonal anti-CREB 
(1:1,000 in blocking buffer; Cell Signaling Technology). Subsequently, the 
membranes were incubated for 1 h with horseradish peroxidase -conjugated goat 
anti-rabbit antibody (1:5,000; Jackson Immuno-Research, West Grove, PA) at room 
temperature. Finally, immunocomplexes were detected by enhanced 
chemiluminescence (Pierce, Rockford, IL) and signals quantified using Image J 
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software (NIH, Bethesda, MD). For staining of Bad and phospho-Bad, the 
membranes were blocked with 5% nonfat dry milk in TBS containing 0.1% Tween-20 
at room temperature for 1 h, washed 3x for 5 min in TBS-0.1% Tween-20, and 
incubated with the respective antibody in 5% BSA in TBS-0.1% Tween-20 at 4°C 
overnight. Total Bad protein and Bad phosphorylated at Ser155 were detected using 
polyclonal rabbit anti-Bad antibody (1:1,000; Cell Signaling Technology) and 
polyclonal anti phospho-Bad-Ser155 antibody (1:1,000; Cell Signaling Technology), 
respectively. Incubation with secondary antibody and detection procedures were 
performed as described above.  
 
Northern blot analysis. 
Cells were lysed by adding TriFast reagent (1 ml/85 mm dish; PeqLab, Erlangen, 
Germany), and total RNA was isolated according to the manufacturer's 
recommendations. Aliquots (20 μg) were separated on 1.0% agarose-formaldehyde 
gels, transferred to nylon membranes (Roche, Mannheim, Germany), and 
immobilized by UV crosslinking. Relative abundance of the respective mRNAs was 
monitored by hybridization with biotin-labeled cDNA probes specific for COX-2 and 
human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as described in detail 
previously (37). After hybridization, the membranes were washed twice with 2 x SSC-
0.1% SDS at room temperature and twice with 1 x SSC in 0.1% SDS at 50°C. 
Nonradioactive detection procedures were performed using a commercially available 
kit (Pierce, Rockford, IL) according to the manufacturer's protocol. Band intensity was 
quantified using Image J software, and COX-2 mRNA abundance was normalized to 
that of GAPDH to correct for differences in RNA loading.  
 
90 
 
Reporter gene assays. 
To monitor activation of potential signaling pathways, MDCK cells were transfected 
stably with appropriate reporter constructs based on secreted alkaline phosphatase 
(SEAP; Clontech, Palo Alto, CA). (1) In pCRE-SEAP (Clontech), expression of SEAP 
is under control of a CRE; (2) In pNF-κB-SEAP (Clontech), transcription of SEAP is 
driven by a nuclear factor (NF)-κB site (3); pTonE-SEAP is controlled by a tandem 
tonicity-responsive element (TonE) motive and was constructed as described 
previously (37). MDCK cells in 85-mm dishes were transfected with 20 μg DNA at a 
20:1 molar ratio of the respective SEAP construct and pcDNA3-LacZ (Invitrogen, 
Karlsrühe, Germany) as described in detail elsewhere (37). After the selection with 
600 μg/ml geneticine (Sigma), 24 clones for each construct were expanded and 
assayed for inducible reporter gene expression after stimulation with 20 μM forskolin 
(pCRE-SEAP), 10 ng / ml tumor necrosis factor-α (pNF-κB-SEAP), or by adding an 
additional 100 mM NaCl to the medium (pTonE-SEAP). Clones with highly inducible 
SEAP expression were pooled and used in experiments at passages 3–10.  
In reporter assays, the cells were seeded in 24-well plates. After reaching 
confluence, the medium containing geneticine was replaced by DMEM without 
phenol red lacking geneticine, and the cells were treated as indicated. After 24 h,    
50 μl medium was transferred to a 96-well plate that was sealed and incubated in a 
water bath at 65°C for 30 min to inactivate endogenous alkaline phosphatase activity. 
For SEAP detection, 150 μl p-nitrophenyl phosphate liquid substrate (Sigma) was 
added, and samples were incubated at room temperature for appropriate periods. 
Finally, SEAP activity was assessed at 405 nm in a microplate reader.  
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Generation of MDCK cells expressing dominant-negative CREB. 
For disruption of intracellular cAMP-PKA signaling, MDCK cells were transfected with 
the plasmid pCMV-KCREB (Clontech), encoding a mutant variant of the human 
CREB protein that contains mutations in the DNA-binding domain, which forms 
dimers with endogenous CREB and blocks the ability of endogenous CREB to bind 
to CRE (45). Transfections were performed using the calcium phosphate method as 
previously described (36). After selection of stable clones with 800 μg / ml geneticine, 
24 clones obtained for each vector construct were expanded and further 
characterized. To identify MDCK cell clones with significant repression of PKA 
signaling, each clone was transiently transfected with a CRE-driven reporter 
construct (pCRE-SEAP; Clontech), followed by stimulation with forskolin (20 μM) for 
24 h. From the 24 clones initially obtained in cells transfected with pCMV-KCCREB, 
3-4 showed strongly reduced response to forskolin; these were pooled and used in 
further experiments. Pooled clones transfected with wild-type CREB were used as 
controls. For transient transfection assays, a total of 4 x 106 exponential MDCK cells 
were electroporated with 40 μg of the respective plasmids in 400 μl HEPES-buffered 
saline at 300 V and 950 μF in a 4-mm cuvette, using a Bio-Rad Gene Pulser Xcell 
apparatus.  
 
Determination of COX activity. 
COX activity in cell lysates was determined using a commercially available COX 
activity assay kit (Cayman Chemicals). The measurement is based on the detection 
of the peroxidase activity of COX, which is monitored colorimetrically by the formation 
of oxidized N, N, N′, N′-tetramethyl-p-phenylendiamine (TMPD) at 620 nm. Briefly, 
cells were washed with ice-cold TBS, harvested in 200 μl TBS containing 1 mM 
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EDTA and 1% (vol/vol) broad-specificity protease inhibitor cocktail (Sigma), and 
lysed mechanically by repeated vigorous passage through a 26-gauge needle. After 
centrifugation at 13000 g for 15 min at 4°C, COX activity was determined in equal 
volumes of the supernatant according to the manufacturer's protocol. To discriminate 
between COX-1 and COX-2 activity, each sample was compared with a 
corresponding one containing an isoenzyme-specific inhibitor for COX-1 (SC-560, 
330 nM), and COX-2 (DuP-697, 300 nM), respectively. Subsequently, COX activity 
was normalized to the protein concentration in the cell lysate (expressed as U/μg 
protein).  
 
PGE2 measurement. 
PGE2 concentrations in 100-μl medium aliquots were determined using a 
commercially available assay (PGE2 EIA Kit; Cayman Chemicals) according to the 
manufacturer's protocol. Plates were read at 405 nm in a plate reader, and PGE2 
concentrations were determined from the standard curve.  
 
COX-2 promoter activity assay. 
For construction of a canine COX-2 reporter vector, genomic DNA from MDCK cells 
was used as template. The 5'-flanking region reaching from bp −825 to +1 of the 
canine COX-2 gene was amplified by PCR, using primers                                            
5′-GGTGGCCAAAGTGGTGAA-3′ (sense) and 5′-AGACGCTCGCTGCAAGTT-3′ 
(antisense), and subcloned into the pJET vector by use of the CloneJET PCR 
Cloning Kit (Fermentas, St. Leon-Rot, Germany) according to the manufacturer's 
recommendations. The resulting plasmid pJET-COX-2-Promoter was cut with NcoI, 
blunted with T4 DNA polymerase, and subsequently cut with XhoI to mobilize the 
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fragment containing the COX-2 promoter region, which was subcloned into the 
pSEAP-basic vector (Clontech), using restriction sites XhoI and NruI. The sequence 
of the resulting plasmid pSEAP-COX-2-Promoter, containing the COX-2 promoter 
fragment (bp −825 to +1) upstream of a secreted alkaline phosphatase reporter 
gene, was verified by sequencing. A computer-based analysis of the COX-2 
promoter region using the TESS algoritm (www.cbil.upenn.edu/cgi-bin/tess) revealed 
a putative CRE site at bp −78 to −74 (5′-CGTCA-3′) in the COX-2 promoter region. 
This site was deleted from the plasmid pSEAP-COX-2-Promoter of the first four 
nucleotides (CGTC) using the QuikChange Site-Directed Mutagenesis Kit 
(Stratagene, La Jolla, CA). The primers for the mutagenesis were                             
5′-GTGGAAAGAAACAGTCATG*ACGTGGGCTTAGTTATCAT-3′ (sense) and            
5′-ATGATAACTAAGCCCACGT*CATGACTGTTTCTTTCCAC-3′ (antisense; the * 
marks the position where the four nucleotides were deleted). The mutagenesis of the 
CRE site was verified by sequencing the resulting plasmid pSEAP-COX-2 Promoter-
CRM. MDCK cells were transfected with pSEAP-COX-2-Promoter and pSEAP-  
COX-2 Promoter-CRM using Lipofectamine (Invitrogen, Carlsbad, CA) according to 
the manufacturer's recommendations. Reporter gene assays were performed as 
described above.  
 
Determination of caspase-3 activity. 
Caspase-3 activity was assessed using an assay based on the cleavage of a 
synthetic p-nitroaniline-conjugated caspase-3 substrate (Asp-Glu-Val-Asp; CaspACE 
Assay System; Promega, Madison, WI). The cells were treated as indicated, 
subsequently washed with ice-cold PBS, and disrupted by the addition of 100 μl lysis 
reagent (Promega) per 35-mm dish, followed by three freeze-thaw cycles. After 
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centrifugation at 13,000 g for 20 min at 4°C, activity of caspase-3 was measured 
according to the manufacturer's recommendations using 20 μl supernatant. Caspase-
3 activity was determined by increase in A405 and was normalized to the protein 
concentration of the cell lysates. Relative caspase-3 activity is expressed as 
picomoles p-nitroaniline liberated per microgram protein in 1 h.  
 
Immunohistochemistry. 
All experiments were conducted in accordance with German federal laws relating to 
animal experimentation. The kidneys of male Wistar rats (200–250 g) were cut into 2-
mm slices along the cortico-medullary axis, fixed overnight in 4% paraformaldehyde 
in phosphate buffer, embedded in paraffin, and cut into 4-μm-thick sections. After 
pretreatment in a microwave for 3 x 5 min, endogenous peroxidase activity was 
blocked with 3% H2O2 for 10 min. Thereafter, the sections were rinsed with PBS, and 
nonspecific binding sites were blocked by incubation with 3% goat serum in PBS for 
30 min at room temperature. Subsequently, sections were incubated with rabbit 
polyclonal COX-2 antiserum (Cayman Chemicals), diluted 1:600 in PBS overnight at 
4°C, and subsequently with secondary biotin-conjugated goat anti-rabbit antiserum 
(1:200 in 3% goat serum in PBS). Immunocomplexes were visualized using an ABC-
detection kit according to the manufacturer's protocol (Vectastain; Vector 
Laboratories) with diaminobenzidine tetrahydrochloride-0.1% H2O2 in PBS as 
chromogenous substrate. Finally, the sections were counterstained with hemalaun 
and mounted. In negative controls, the primary antibody was omitted.  
 
Presentation of data and statistical analysis. 
Data are presented as means ± SE. The significance of differences between means 
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was determined using Student's t-test, or ANOVA for multiple comparisons. P < 0.05 
was regarded as significant.  
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Results 
 
Effect of PGE2 on tonicity-induced COX-2 expression.  
The present study addressed the hypothesis that PGE2 affects the expression of 
COX-2 via a feedback mechanism under hypertonic conditions and investigated the 
signaling pathways and functional consequence of this putative feedback loop in 
closer detail. In the first step, the time course of tonicity-induced COX-2 expression 
and the effect of PGE2 were assessed. As demonstrated in Fig. 1, adding PGE2 
under hypertonic conditions caused an increase in COX-2 mRNA (Fig. 1A) and 
protein (Fig. 1B) levels. This effect became evident at PGE2 concentrations of 5 μM 
and higher. Therefore, in the following experiments, the lowest effective PGE2 
concentration, i.e., 5 μM, was used. Adding PGE2 to isotonic medium at even high 
concentrations (i.e., 20 μM) failed, however, to elicit any effect on COX-2 expression 
(Fig. 2A). In addition, the stimulatory effect of PGE2 on COX-2 induction was also 
evident after raising the medium tonicity quasilinearly and gradually over several 
hours as occurs in the kidney in vivo following stimulation of the urinary concentrating 
mechanism (Fig. 2B).  
Figure 3 shows the time course of COX-2 induction in response to osmotic stress in 
the absence and presence of PGE2. COX-2 mRNA (Fig. 3A) and protein (Fig. 3B) 
levels were increased transiently, reaching a maximum after 6 and 24 h after 
elevating the medium tonicity, respectively. COX-2 induction was potentiated 
substantially in the presence of PGE2 in the hypertonic medium. 
 
 
 
97 
 
Effect of PGE2 on COX-2 activity. 
To assess whether the observed changes in COX-2 expression on mRNA and 
protein levels are paralleled by alterations in enzyme activity, the latter was 
determined in cell lysates under the conditions shown in Fig. 4A. COX activity was 
increased significantly by hypertonicity and was further elevated significantly by 
PGE2, an effect that was diminished by the protein kinase A (PKA) inhibitor H-89.  
Addition of the specific COX-2 inhibitor DuP-678 reduced total COX activity in the 
samples by about 60% (Fig. 4B), whereas the selective COX-1 inhibitor SC-560 had 
only marginal effects, indicating that COX-2 is the major COX isoform accounting for 
COX activity during osmotic stress and that PGE2 stimulates COX-2 activity during 
osmotic stress. To address whether a rise in cellular ionic strength may reduce COX-
2 activity under hypertonic conditions, the assay buffer was adjusted with KCl to 
intracellular levels as observed during osmotic stress. We observed, however, no 
significant changes in COX activity in this approach, suggesting that an increase in 
cellular ionic strength does not significantly modulate COX activity (not shown).  
To directly address whether the proposed PGE2-cAMP pathway stimulates PGE2 
production, PGE2 concentration in the medium was measured from MDCK cells 
incubated under isotonic conditions or under hypertonic conditions in the presence or 
absence of the cAMP mimetic dibutyryl-cAMP. As demonstrated in Fig. 5, osmotic 
stress increased PGE2 release severalfold, which was further more than doubled by 
the addition of dibutyryl-cAMP. The reason why COX activity as measured in the 
activity assay does not increase to the same extent as PGE2 production is unknown; 
however, this phenomenon may be due to the fact that COX activity is determined in 
cell lysates using an in vitro assay, which may not reflect accurately the environment 
inside of intact cells.  
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Signaling pathways involved in stimulation of COX-2 induction by PGE2. 
The next aim was to investigate potential signaling pathways for the observed 
positive feedback effect of PGE2 on COX-2 expression during osmotic stress. 
Preliminary experiments indicated that a cAMP-dependent mechanism is involved. 
This is inferred from the observation that PKA inhibition drastically reduced cell 
survival during osmotic stress and the fact that PGE2 substantially improves cell 
viability under hypertonic conditions, suggesting a mechanism that involves signaling 
through EP2 and / or EP4 receptors. This would be consistent with previous findings 
demonstrating stimulation of COX-2 expression in an EP2 receptor, PKA-dependent 
manner in a murine intestinal polyposis model (41), and prosurvival effects of PGE2 
following UVB irradiation, which were mediated by EP2 and / or EP4 receptors (6, 
16). To address this issue during osmotic stress, MDCK cells were pretreated with 
the EP2 receptor antagonist AH-6809 or the EP4 antagonist AH-23848 before 
increasing the medium tonicity in the presence of PGE2. As shown in Fig. 6, AH-6809 
diminished the stimulatory effect on COX-2 induction at the mRNA (Fig. 6A) and 
protein (Fig. 6B) level, whereas no significant effect was evident in the presence of 
AH-23848. Accordingly, forskolin, an activator of adenylate cyclase, and the cAMP 
mimetic dibutyryl-cAMP mimicked the stimulatory effect of PGE2 on COX-2 
expression, thus supporting the notion that this effect is mediated by an EP2-
dependent increase in intracellular cAMP. In agreement, the response to PGE2 was 
abolished by H-89, an inhibitor of PKA. To confirm the expression of players in this 
signaling pathway in MDCK cells, immunoblot analyses for EP2 and CREB were 
performed. As shown in Fig. 6C, both the putative upstream (EP2) and downstream 
(CREB) signaling molecules are expressed in these cells under isotonic and 
hypertonic conditions. Accordingly, the presence of functional cAMP-PKA signaling in 
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response to PGE2 has been demonstrated recently (33).  
 
Role of the CREB-CRE pathway in stimulation of COX-2 induction by PGE2.  
The above observations are compatible with the view that the positive feedback 
effect of PGE2 on COX-2 is conveyed by PKA-mediated activation of CREB with 
subsequent stimulation of CRE, thereby enhancing COX-2 transcription. Particularly, 
signaling through both NF-κB and CREB is involved in COX-2 induction in response 
to various stimuli (8, 23, 44, 47). To identify the pathway involved in the present 
study, activation of these signaling pathways was assessed in MDCK cells stably 
transfected with reporter gene constructs driven by NF-κB or CRE sites, respectively. 
CRE-driven reporter activity under the individual conditions is shown in Fig. 7A. In the 
absence of PGE2, no difference in CRE-driven reporter activity was evident by raising 
the medium osmolality from 300 to 500 mosmol/kg H2O. PGE2, added under isotonic 
conditions, enhanced reporter activity about fivefold, whereas addition of PGE2 to 
hypertonic medium increased reporter activity 15- to 17-fold compared with isotonic 
controls. In general, reflecting the effects observed on COX-2 expression, CRE-
driven reporter activity was not affected by AH-23848 but diminished by the EP2 
antagonist AH-6809 and the PKA inhibitor H-89. Forskolin, as well as dibutyryl-
cAMP, enhanced reporter activity comparably to PGE2 (Fig. 7A). In contrast to the 
CRE-driven construct, hyperosmolality in the absence or presence of PGE2 caused 
no significant changes in reporter activity in MDCK cells transfected with a reporter 
construct under the control of a NF-κB site (Fig. 7B). Although COX-2 is not a known 
TonEBP target gene, the impact of PGE2 on TonE-stimulated reporter activity was 
additionally investigated. In MDCK cells stably transfected with a TonE-driven 
reporter vector, hypertonicity elicited a robust increase in reporter gene expression, 
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as expected; however, this response was not further stimulated by PGE2 (Fig. 7C).  
To directly address the stimulatory effect of PGE2 on COX-2 expression at the 
promoter level, a portion of the canine COX-2 promoter was cloned from MDCK cells. 
In the resulting construct, the SEAP gene is driven by a −825 to +1 canine COX-2 
promoter fragment. Under hypertonic conditions, reporter activity was only 
moderately increased compared with isotonic conditions, whereas addition of PGE2 
further significantly enhanced reporter activity (Fig. 8A). The reason for the minor 
degree of induction compared with the induction at the mRNA and protein level may 
be caused by regulatory elements upstream of −825 that are required for full 
transcriptional activation during osmotic stress. Accordingly, reporter activity under 
hypertonic conditions in the present experiments was in the same range as in a 
previous study by Yang et al. (49). 
A database search revealed the presence of a putative CRE at bp −78 to −74 in the 
canine COX-2 promoter. To investigate the contribution of this CRE to the stimulatory 
effect of PGE2 on COX-2 expression, the respective sites were deleted by site-
directed mutagenesis. In MDCK cells transfected with the CRE-deleted construct, 
reporter activity was elevated to the same extent as with the wild-type promoter 
under hypertonic conditions, whereas no further increase was evident in the 
presence of PGE2 (Fig. 8B). These observations suggest that CRE signaling 
mediates the stimulatory effect of PGE2 on COX-2 induction during osmotic stress.  
In summary, the above findings favor a cAMP-PKA-CREB-dependent pathway that 
mediates enhanced COX-2 expression in the presence of PGE2. To test this 
hypothesis directly, MDCK cells were transfected with wild-type or dominant-negative 
CREB (KCREB) (45). As demonstrated in Fig. 9A, in cells transfected with wild-type 
CREB, tonicity-induced COX-2 protein expression was further significantly increased 
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by PGE2. This effect was however abolished in MDCK cells transfected with 
dominant-negative CREB, further strengthening the concept that the stimulatory 
effect of PGE2 likely relies on an EP2-cAMP-PKA-CREB-dependent pathway. The 
latter experiments were performed with stably transfected MDCK cells. To exclude 
any bias by selecting and expanding single cell clones, the experiment was repeated 
in transient transfection assays, i.e., MDCK cells were electroporated with the 
respective expression constructs. Immunoblot analysis with an antibody that detects 
both wild-type CREB and KCREB showed substantially higher immunoreactivity in 
electroprated cells compared with nontransfected cells, suggesting efficient gene 
delivery (Fig. 9C). Regarding COX-2 expression under the various experimental 
conditions, essentially the same results were obtained as in stably transfected cells 
(Fig. 9B), supporting the notion that CREB-CRE signaling indeed mediates the 
positive feedback effect of PGE2 on COX-2.  
 
Effect of PGE2 on biochemical indices of apoptosis during osmotic stress. 
MDCK cell were subjected to hypertonic medium (650 mosmol/kg H2O by NaCl 
addition) for 12 h. After this period, the cells were processed for measurement of 
caspase-3 activity. As demonstrated in Fig. 10, caspase-3 activity was 8- to 10-fold 
higher under hypertonic conditions than in cells kept at 300 mosmol/kgH2O. Tonicity-
induced increase in caspase-3 activity was however reduced significantly in the 
presence of PGE2, forskolin, or dibutyryl-cAMP. Conversely, EP2 antagonism with 
AH-6809 as well as H-89 diminished the protective effect of PGE2, whereas the EP4 
antagonist AH-23848 had no significant effect (Fig. 10).  
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Phosphorylation of pro-apoptotic Bad by PGE2. 
Bad is a pro-apoptotic member of the Bcl-2 family that promotes cell death by binding 
to and inactivating anti-apoptotic Bcl-xL and Bcl-2. This pro-apoptotic activity of Bad 
is inhibited by PKA-mediated phosphorylation at Ser155 (9, 27, 53). Because 
phosphorylation at Ser155 disrupts the binding of Bad to pro-survival Bcl-2 proteins, 
thereby blocking apoptosis, this event might provide a potential explanation for the 
protective effect of PGE2 during osmotic stress. To address this hypothesis, 
phosphorylation of Bad at Ser155 was assessed by immunoblot analysis. As evident 
from Fig. 11, Ser155-phosphorylated Bad protein was readily detectable in cells 
exposed to elevated ambient tonicity, but phosphorylation was considerably higher 
when PGE2 was added to the hypertonic medium. This effect was mimicked by 
forskolin and blunted by the PKA inhibitor H-89. Total Bad protein abundance 
appears to be unchanged during the several treatments. In summary, PGE2 
promotes Bad phosphorylation at Ser155 in a cAMP-PKA-dependent pathway, which 
correlates with reduced caspase-3 activity during osmotic stress.  
 
Expression of COX-2 in the renal medulla. 
Although MDCK cells are frequently used as a model system for medullary collecting 
duct cells, the expression of COX-2 in the latter cells has been inconsistently 
demonstrated in the literature. To confirm the physiological relevance of the findings 
presented in the previous sections, intramedullary COX-2 expression was 
determined by immunohistochemistry on the kidneys of adult Wistar rats with free 
access to water. In the renal papilla, COX-2 immunoreactivity was most prominent in 
medullary interstitial cells, whereas inner medullary collecting duct (IMCD) cells 
exhibited no or only very faint staining (Fig. 12, A and B). These findings are 
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consistent with previous studies addressing the cellular localization of COX-2 in the 
renal inner medulla (13, 50), although COX-2 expression was also detected in IMCD 
cells in water-deprived rats (49). In the outer medulla, COX-2 immunoreactivity was 
localized specifically in outer medullary collecting duct cells, whereas other tubular 
epithelial cells and interstitial cells showed no or only minimal COX-2 
immunoreactivity (Fig. 12, C and D). Immunostaining for COX-2 was also evident in 
the initial part of the IMCD (Fig. 12C). Thus the MDCK cell model that we used in the 
present study appears at least adequate in the context of OMCD cells, in addition, a 
functional relevance of the proposed positive feedback effect of PGE2 on COX-2 
expression is conceivable in IMCD cells.  
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Discussion 
 
COX-derived prostanoids exert multiple essential functions within the kidney. In the 
renal medulla, locally produced PGE2 reduces sodium and water reabsorption in the 
medullary thick ascending limb and the collecting duct, respectively, effects that are 
mediated in an autocrine/paracrine manner (18, 21). Moreover, PGE2 dilates 
descending vasa recta, thereby buffering the constrictor effects of ANG II, AVP, and 
catecholamines during physiological stress, an action that is vitally important to 
prevent hypoxic damage to renal medullary cells (39). In contrast to most other 
tissues, COX-2 is constitutively expressed in the renal medulla and is induced further 
by dehydration when the urinary concentrating mechanism is stimulated (49). The 
relevance of renomedullary COX-2-derived PGE2 is underscored by the observation 
that selective COX-2 inhibitors are associated with renal side effects similar to those 
observed with traditional nonselective nonsteroidal anti-inflammatory drugs (14, 40).  
We have demonstrated recently that PGE2 favors the adaptation of renal medullary 
cells to elevated ambient tonicities as present in the renal papilla during antidiuresis 
(25, 37). In addition to the enhanced expression of several osmosensitive genes (37), 
COX-2 was induced even more vigorously in response to hypertonicity in the 
presence of PGE2 following a nearly gradual increase in ambient tonicity (37). 
Consistent with this finding, corresponding observations were evident in the present 
experiments, where a step increase in extracellular osmolality was employed (Figs. 1 
and 2). In aggregate, these findings confirm the existence of a positive feedback loop 
of PGE2 on COX-2 expression during osmotic stress. The present study thus aimed 
to characterize this phenomenon in more detail and to delineate the underlying 
signaling pathways and the functional relevance of this observation.  
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PGE2 substantially increased tonicity-induced COX-2 mRNA and protein expression 
and activity, an effect that appears to depend on signaling through EP2 receptors 
with subsequent formation of cAMP and activation of PKA (Figs. 1–3). Both types of 
Gαs-coupled EP receptors, i.e., EP2 and EP4, have been detected in MDCK cells (26, 
38). Although the precise cellular localization of EP2 receptors in the kidney is not 
well defined, EP2 mRNA has been detected in the inner and outer medulla of the rat 
kidney but not in the cortex (19, 20). Furthermore, mice with targeted disruption of 
the EP2 receptor develop salt-sensitive hypertension, suggesting that EP2 plays an 
important role in the renal medulla (22). In contrast to the intrarenal distribution of 
EP2, EP4 is expressed abundantly in glomeruli but is not detected in the renal 
medulla (5). Consistently, in the present study, both the EP2 antagonist AH-6809 and 
the PKA inhibitor H-89 blunted the stimulatory effect of PGE2 on COX-2 expression, 
whereas the EP4 inhibitor AH-23848 had no significant effect (Fig. 6). Conversely, 
the cAMP mimetics forskolin and dibutyryl-cAMP potently enhanced COX-2 
expression under hypertonic conditions (Fig. 6). However, we did not address the 
effect of EP2 or EP4 inhibition in the absence of exogenously added PGE2 in the 
present study nor did we examine the effect selective COX-2 inhibitors. Thus we 
cannot delineate the role of endogenously produced PGE2 in MDCK cells nor can be 
completely excluded that alternative pathways or interactions with members of other 
signaling cascades are involved in the observed effects. cAMP exerts a multitude of 
biological actions and additional effectors of cAMP other than PKA have been 
identified (15). Thus our primarily inhibitor-based approach does not completely rule 
out the possibility that signaling events distinct from the classical Gs-coupled 
receptor-cAMP-PKA-CREB pathway contribute to the stimulatory effect of PGE2 on 
COX-2 expression during osmotic stress. Nevertheless, the most likely explanation 
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for the observed effects is activation of the classical cAMP-PKA signaling cascade, 
which is in agreement with previous findings in a murine intestinal polyposis model 
(41). In the latter investigation, COX-2 expression was boosted by PGE2, acting 
through EP2 receptors and elevation in intracellular cAMP levels in a positive 
feedback loop (41).  
Although the present data support a role of cAMP-PKA signaling in COX-2 
expression and cell survival under hypertonic conditions, other studies failed to 
detect activation of PKA in IMCD cells (28) and stimulation of cAMP production in 
HepG2 cells (10) in response to hypertonicity. Nevertheless these findings are 
consistent with the present observations that osmotic stress only negligibly increases 
CRE-driven reporter activity in the absence of exogenous PGE2, whereas the latter is 
robustly enhanced in the presence of PGE2 (Fig. 7A). These observations may either 
relate to different cell types used, or even of greater importance, that PGE2 may be 
more readily available for renal medullary cells in an auto-/paracrine manner in the 
local cellular environment in the renal medulla in situ and that cell culture systems 
represent a simplification of the complex in vivo situation. Although MDCK are 
frequently used to address cellular and molecular aspects in osmoadaptation of renal 
medullary cells, their precise origin is unknown, which may represent a limitation of 
the present study. In addition, we did not evaluate the effect of endogenously 
produced PGE2 or the effect of EP2 and EP4 inhibitors in the absence of exogenous 
PGE2, which may represent a further limitation.  
Several consensus elements including those for NF-κB and CRE have been 
identified as regulatory sequences in the promoter region of COX-2 from various cell 
types from different species that are involved in COX-2 induction during cell stress 
(47, 48). In MDCK cells transfected with a CRE-driven reporter construct, reporter 
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gene expression closely correlated with COX-2 abundance under the various 
experimental conditions (Fig. 6A), which was not the case in cells transfected with a 
reporter construct under control of a NF-κB site (Fig. 6B). A functional contribution of 
CREB-CRE signaling is further supported by the observation that deletion of a 
potential CRE in the canine COX-2 promoter abolishes the stimulatory effect of PGE2 
(Fig. 8), which was also the case after transfection with dominant-negative CREB 
(Fig. 9). Interestingly, under isotonic conditions, PGE2 was not sufficient to enhance 
COX-2, despite robust induction of CRE-driven reporter activity (Fig. 7A). These 
observations indicate that additional signaling pathways that are activated during 
osmotic stress (i.e., p38, ERK1/2) are required for stimulation of COX-2 expression 
under hypertonic conditions, as previously suggested by findings of our group and 
others (25, 52).  
Furthermore, PGE2 significantly attenuated biochemical indices of apoptosis as 
shown for caspase-3 activity in MDCK cells exposed to tonicities that are found 
routinely in medulla of the concentrating kidney (3). Again, this effect could be 
blunted by EP2, but not EP4 antagonism, and by PKA inhibition, whereas the effect 
of PGE2 could be reproduced by forskolin and dibutyryl-cAMP (Fig. 10), supporting 
the existence of an EP2-cAMP-PKA-dependent pro-survival mechanism that is 
activated by PGE2. Interestingly, a corresponding mechanism has been described 
recently in gamma radiation-mediated apoptosis in mouse intestine and UVB-induced 
apoptosis in mouse skin (6, 16). Notably, both irradiation and hyperosmolality entail 
structural DNA damage, including double-strand breaks (11). In UVB-induced 
apoptosis in mouse skin, COX-2-derived PGE2 inhibited apoptosis via an EP2-cAMP-
PKA-dependent pathway, a response mediated by phosphorylation of the pro-
apoptotic protein Bad (6). Bad belongs to a family of proteins regulating survival 
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factor / apoptosis checkpoints in the cellular death machinery, which either promote 
survival (e.g., Bcl-2, Bcl-xL), or apoptosis (e.g., Bad, Bak) (9). Activated PKA 
phosphorylates Bad at Ser155, which inactivates the pro-apoptotic function of Bad by 
impeding the cytotoxic interaction of Bad with anti-apoptotic Bcl-2 and Bcl-xL proteins 
at the mitochondrial membrane (9, 53). This mechanism is of particular importance 
for survival factors acting through their cognate cell surface receptors and appears to 
be crucial in epithelial cells (24, 43). In MDCK cells, overexpression of Bad has been 
shown to increase caspase-3 activity, which was diminished by phosphorylation of 
Bad (17). These findings are in good agreement with the present results 
demonstrating that Bad is phosphorylated at Ser155 in the presence of PGE2 and 
forskolin, known activators of PKA, whereas PGE2-induced Bad phosphorylation is 
prevented by PKA inhibition with H-89 (Fig. 11). Notably, Bad phosphorylation was 
associated with reduced caspase-3 activity during osmotic stress, whereas 
pharmacological inhibition of the EP2-cAMP-PKA axis significantly increased 
caspase-3 activity (Fig. 8). Although the present data are consistent with an anti-
apoptotic mechanism related to phosphorylation of Bad, they do not establish a 
causal role of the proposed mechanism in the present model.  
In conclusion, the present study demonstrates that the major medullary prostanoid, 
PGE2, increases tonicity-induced COX-2 expression and activity in a positive 
feedback loop that likely involves signaling through a PGE2-EP2-cAMP-PKA-CREB-
CRE-dependent pathway. In addition, activation of this mechanism prevents 
biochemical indices of apoptosis during osmotic stress, suggesting that this pathway 
is relevant during osmoadaptation of renal medullary cells. Finally, PGE2 causes 
PKA-dependent phosphorylation of pro-apoptotic Bad, coinciding with reduced 
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apoptotic indices, thereby providing a possible mechanistic link for the prosurvival 
effect of PGE2 under hypertonic conditions.  
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Legends for figures 
 
Figure 1. Effect of prostaglandin E2 (PGE2) on tonicity-induced COX-2 expression. 
MDCK cells were incubated in isotonic (300 mosmol/kg H2O, iso) or hypertonic 
medium (500 mosmol/kg H2O by NaCl addition, NaCl) in the presence of 1, 5, 10, or 
and 20 μM PGE2, or only vehicle ethanol (vehicle). (A) COX-2 mRNA abundance 
was assessed after 6 h incubation by Northern blot analysis. COX-2 mRNA 
expression was normalized to that of GAPDH. Representative blots are shown. 
Means±SEM for n=3; * P<0.05 vs. NaCl and NaCl+vehicle. (B) COX-2 protein 
expression was determined after 24 h by Western blot analysis. To demonstrate 
equal protein loading, the membranes were also stained for actin. Representative 
blots are shown. Means±SEM for n=4-10; * P<0.05 vs. NaCl and NaCl+vehicle. 
 
Figure 2. Effect of PGE2 on COX-2 expression under isotonic conditions and 
following a gradual tonicity increase.  
(A) MDCK cells were exposed to isotonic medium (300 mosmol/kg H2O) in the 
presence of 20 μM PGE2 (iso+PGE2), or vehicle ethanol (iso+vehicle). The 
membrane was reprobed for GAPDH to demonstrate comparable mRNA loading. 
Representative blots including 4 independent experiments are shown. (B) MDCK 
cells were exposed to isotonic medium (300 mosmol/kg H2O, iso) or to medium in 
which the osmolality was raised quasi-linearly and gradually to 700 mosm/kgH2O 
over a period of 4 h by repeated addition of NaCl in presence of PGE2 (NaCl+PGE2) 
or vehicle ethanol (NaCl+vehicle). After an additional 6 h, COX-2 mRNA expression 
was determined by Northern blot analysis. The signal for COX-2 was normalized to 
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GAPDH to correct for differences in RNA loading. Means±SEM for n=4; * P<0.05 vs. 
iso; # P<0.05 vs. NaCl+vehicle; Representative blots are shown. 
 
Figure 3. Time course of COX-2 expression following osmotic stress.  
MDCK cells were exposed to hypertonic medium (500 mosm/kg H2O by NaCl 
addition) for the indicated periods in the presence of 5 μM PGE2 (NaCl+PGE2) or 
only vehicle ethanol (NaCl+vehicle). (A) COX-2 mRNA abundance was determined 
by Northern blot analysis. COX-2 mRNA expression was normalized to that of 
GAPDH to correct for differences in RNA loading. Representative blots from two 
independent experiments are shown. (B) COX-2 protein expression was determined 
by Western blot analysis. The membranes were also stained for actin to demonstrate 
equal protein loading. Representative blots are shown. Means±SEM for n=4; * 
P<0.05 vs. NaCl+vehicle. 
 
Figure 4. Effect of PGE2 on COX activity under hypertonic conditions. 
 (A) MDCK cells were kept in isotonic medium (300 mosm/kgH2O, iso) or in 
hypertonic medium (500 mosmol/kg H2O by NaCl addition, NaCl) in the presence of 5 
μM PGE2 (PGE2), or vehicle ethanol (vehicle). In some experiments, the cells were 
pretreated with H-89 (20 μM) prior to addition of 5 μM PGE2 under hypertonic 
conditions (PGE2+H-89). After 24 h, COX-2 activity was determined as described in 
Methods. Means±SEM for n=3-4; § P<0.05 vs. iso; * P<0.05 vs. NaCl and 
NaCl+vehicle; # P<0.05 vs. NaCl+PGE2. (B) COX isoform activity from cells kept in 
hypertonic medium (500 mosm/kgH2O) in the presence of 5 μM PGE2 was assessed 
by addition of an iso-enzyme specific inhibitor for COX-1 (SC-560) and COX-2 (DuP-
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697), respectively, to differentiate COX-1 from COX-2 activity. Means±SEM for n=4; * 
P<0.05 vs. SC-560.  
 
Figure 5. Effect of cAMP signaling on PGE2 production under hypertonic conditions. 
MDCK cells were kept in isotonic medium (300 mosmol/kg H2O, iso) or in hypertonic 
medium (500 mosmol/kg H2O by NaCl addition, NaCl) in the presence of 1 mM 
dibutyryl-cAMP 5 μM PGE2 (cAMP), or vehicle PBS (vehicle). After 24 h, PGE2 
concentration in the medium was determined as described in Methods. Means±SEM 
for n=4; * P<0.05 vs. iso; # P<0.05 vs. NaCl+vehicle. 
 
Figure 6. Signaling pathways involved in PGE2-mediated COX-2 stimulation during 
osmotic stress.  
MDCK cells were incubated in isotonic medium (300 mosmol/kg H2O, iso) or in 
hypertonic medium (500 mosmol/kg H2O by NaCl addition, NaCl). Where indicated, 
the cells were exposed to 5 μM PGE2 (PGE2) or vehicle ethanol (vehicle) under 
hypertonic conditions. In experiments with pharmacological inhibitors, the cells were 
pretreated with 30 μM AH23848 (PGE2+AH23848), 10 μM AH6809 (PGE2+AH6809), 
or 20 μM H-89 (PGE2+H-89), respectively, prior to adding PGE2. In some 
experiments, the cells were treated with 10 μM forskolin (forskolin), or 1mM dibutyryl-
cAMP (dibutyryl-cAMP) under hypertonic conditions as indicated. (A) COX-2 mRNA 
was determined after 6h incubation by Northern blot analysis. COX-2 mRNA 
abundance was normalized to that of GAPDH. Representative blots are shown. 
Means±SEM for n=2. (B) After 24 h incubation, COX-2 protein expression was 
assessed by Western blot analysis. To demonstrate equal protein loading, the 
membranes were also stained for actin. Representative blots are shown. 
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Means±SEM for n=5-10; * P<0.05 vs. NaCl; # P<0.05 vs. PGE2. (C) Expression of 
EP2 and CREB in MDCK cells under isotonic (iso) or hypertonic conditions (NaCl). 
Representative blots are shown. 
 
Figure 7. Effect of PGE2 on CRE, (NF)-κB, and TonE reporter activity.  
MDCK cells transfected stably with reporter constructs driven by cAMP-responsive 
element (CRE), nuclear factor-kappa B (NF-κB), or tonicity-responsive element 
(TonE) sites were treated for 24 h as indicated. Subsequently, relative reporter 
activity was determined as described in Methods. (A) MDCK cells, stably transfected 
with a CRE-driven reporter construct were exposed to isotonic medium (300 
mosmol/kg H2O, iso) or hypertonic medium (500 mosmol/kg H2O by NaCl addition, 
NaCl) in the presence of 5 μM PGE2 (PGE2) or vehicle ethanol (vehicle). In 
experiments with pharmacological inhibitors, AH23848 (30 μM), AH6809 (10 μM), or 
H-89 (20 μM) were added 30 min prior to addition of PGE2. In some experiments, the 
cells were treated with 10 μM forskolin (forskolin), or 1mM dibutyryl-cAMP 
(dibutyrylcAMP) under hypertonic conditions as indicated. Means±SEM for n=2-5; * 
P<0.05 vs. NaCl; # P<0.05 vs. NaCl+PGE2. (B) MDCK cells, stably transfected with a 
NF-κB-driven reporter construct, were incubated in isotonic (iso) or hypertonic (500 
mosmol/kg H2O by NaCl addition) conditions in presence of 5 μM PGE2 (NaCl+PGE2) 
or vehicle ethanol (NaCl+vehicle). As positive control, the cells were exposed to 100 
ng / ml tumor necrosis factor-α (TNF-α). Means±SEM for n=3-6; * P<0.05 vs. all other 
conditions. (C) MDCK cells, stably transfected with a TonE-driven reporter construct 
were incubated in isotonic (iso) or hypertonic (500 mosmol/kg H2O by NaCl addition) 
medium in the presence of 5 μM PGE2 (NaCl+PGE2) or vehicle ethanol 
(NaCl+vehicle). Means±SEM for n=4; * P<0.05 vs. iso. 
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Figure 8. Stimulation of COX-2 promoter reporter activity by CRE signaling. 
(A) MDCK cells were transfected with reporter vector under control of a -825 to +1 
fragment of the canine COX-2 promoter. Subsequently, the cells were incubated for 
24 h in isotonic (iso) or hypertonic medium (500 mosmol/kg H2O by NaCl addition) in 
the presence of 5 μM PGE2 (NaCl+PGE2) or only vehicle ethanol (NaCl+vehicle) prior 
to determination of reporter activity. Means±SEM for n=6-10; * P<0.05 vs. 
NaCl+vehicle. (B) MDCK cells were transfected with the COX-2 promoter-driven 
reporter construct as described in (A), in which a putative CRE at bp -78 to -74 was 
deleted. Subsequently, the cells were treated as in (A) and processed for analysis of 
reporter activity. Means±SEM for n=6-10. 
 
Figure 9. Effect of dominant-negative CREB on stimulation of tonicity-induced COX-2 
expression by PGE2.  
(A) MDCK cells stably transfected with wild-type cAMP responsive element binding 
protein (CREB) or dominant-negative CREB (KCREB) were incubated in isotonic 
(300 mosm/kgH2O, iso) or hypertonic medium (500 mosmol/kg H2O by NaCl addition) 
in the presence of 5 μM PGE2 (NaCl+PGE2) or vehicle ethanol (NaCl+vehicle). After 
24 h, COX-2 expression was determined by Western blot analysis. To demonstrate 
equal protein loading, the membranes were also probed for actin. Representative 
immunoblots are shown. Means±SEM for n=3-4; * P<0.05 vs. NaCl. (B) MDCK cells 
were electroporated with expression vectors for CREB and KCREB as described in 
methods. 24 h after electroporation, the cells were treated and processed as 
described in (A). Means±SEM for n=2. *P<0.05 vs. NaCl+vehicle. (C) Representative 
Western blot analyses for expression of CREB in wild-type MDCK cells, and in 
MDCK cells electroporated with CREB or KCREB expression vectors. 
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Figure 10. Effect of PGE2 on tonicity-induced activation of caspase-3.  
MDCK cells were kept in isotonic medium (300 mosmol/kg H2O, iso) or exposed to 
hypertonic medium (650 mosmol/kg H2O by NaCl addition) in the presence of 5 μM 
PGE2 (PGE2) or vehicle ethanol (vehicle). In experiments with PGE2, the cells were 
also pretreated with 30 μM AH23848 (PGE2+AH23848), 10 μM AH6809 
(PGE2+AH6809), or 20 μM H-89 (PGE2+H-89), respectively, prior to adding PGE2. In 
some experiments, the cells were exposed to 10 μM forskolin (forskolin), or 1 mM 
dibutyryl-cAMP (dibutyryl-cAMP) under hypertonic conditions as indicated. After 12 h, 
caspase-3 activity was determined as described in Methods and expressed as pmol 
pNA liberated per hour per μg protein. Means±SEM for n=3-4; * P<0.05 vs. PGE2; # 
P<0.05 vs. NaCl and vehicle. 
 
Figure 11. Effect of PGE2 on phosphorylation of pro-apoptotic Bad protein.  
MDCK cells were incubated in isotonic (300 mosmol/kg H2O, iso) or hypertonic 
medium (500 mosmol/kg H2O by NaCl addition, NaCl) in the presence of 5 μM PGE2 
(PGE2), 10 μM forskolin (forskolin), or only vehicle ethanol (NaCl). Additionally, the 
cells were pretreated with 20 μM H-89 prior to addition of 5 μM PGE2 under 
hypertonic conditions (PGE2+H-89). After 24 h, total Bad expression, Bad 
phosphorylated at Ser155, and actin abundance was monitored by Western blot 
analysis using specific antibodies. Representative blots of 3 independent 
experiments are demonstrated. 
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Figure 12. Immunohistochemical localization of COX-2 in the inner (A, B) and outer 
(C, D) medulla of the rat kidney.  
COX-2 immunoreactivity is most prominent in interstitial cells in the inner medulla (B) 
and in collecting duct cells in the outer medulla (D). Bars in A and C represent 200 
μm and in B and D 100 μm.  
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